UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

Form 10-Q

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

~~For the quarterly period ended~~

~~March 31,~~ ~~2022~~

For the quarterly period ended September 30, 2022

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

~~For the transition period from~~

For the transition period from _______________to_______________

~~Commission File No.~~

~~1-11596~~

Commission File No. 001-11596

PERMA-FIX ENVIRONMENTAL SERVICES, INC.

(Exact name of registrant as specified in its charter)

Delaware (State or other jurisdiction of incorporation or organization)		58-1954497 (IRS Employer Identification Number)

8302 Dunwoody Place, Suite 250, Atlanta, GA (Address of principal executive offices)		30350 (Zip Code)

(~~770~~) ~~587-9898~~ ~~(Registrant’s telephone number)~~

~~N/A~~

(770) 587-9898

(Registrant’s telephone number)

N/A

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol		Name of each exchange on which registered
Common Stock, $.001 Par Value		PESI	~~PESI~~		NASDAQCapital Markets

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit and post such files).

Yes☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer ☐ Accelerated Filer☒ Non-accelerated Filer ☐ Smaller reporting company ☒Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial standards provided pursuant to Section 13(a) of the Exchange Act ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No☒

Indicate the number of shares outstanding of each of the issuer’s classes of Common Stock, as of the close of the latest practical date.

Class		Outstanding at ~~May 4,~~November 1, 2022
Common Stock, $.001 Par Value		13,324,756 ~~13,256,097~~shares

PERMA-FIX ENVIRONMENTAL SERVICES, INC.

INDEX

				Page No.
PART I			FINANCIAL INFORMATION

	Item 1.	Consolidated Financial Statements	1

		Consolidated Balance Sheets ~~-March 31,~~-September 30, 2022 and December 31, 2021	1

		Consolidated Statements of Operations ~~-Three~~- Three and Nine Months Ended ~~March 31,~~September 30, 2022 and 2021	3

		Consolidated Statements of Comprehensive ~~Loss -Three~~Income (Loss) - Three and Nine Months Ended ~~March 31,~~September 30, 2022 and 2021	4

		Consolidated ~~Statements~~Statement of Stockholders’ Equity ~~-Three~~- Nine Months Ended ~~March 31,~~September 30, 2022 and 2021	5
		~~Consolidated Statements of Cash Flows -Three Months Ended March 31, 2022 and 2021~~	6
		Consolidated Statements of Cash Flows - Nine Months Ended September 30, 2022 and 2021	7

		Notes to Consolidated Financial Statements	78

	Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	2125

	Item 3.	Quantitative and Qualitative Disclosures About Market Risk	32
	~~Item 4.~~	~~Controls and Procedures~~	3240

	Item 4.	Controls and Procedures	41

PART II OTHER INFORMATION			~~OTHER INFORMATION~~

	Item 1.	Legal Proceedings	3342

	Item 1A.	Risk Factors	3342

	Item 6.	Exhibits	3442

PART I - FINANCIAL INFORMATION

~~Item~~ITEM 1. – Financial Statements

PERMA-FIX ENVIRONMENTAL SERVICES, INC.

Consolidated Balance Sheets

	March 31,			December 31,			September 30,			December 31,
	2022			2021			2022			2021
(Amounts in Thousands, Except for Share and Per Share Amounts)	(Unaudited)			(Audited)			(Unaudited)			(Audited)

ASSETS
Current assets:
Cash	$	3,925		$	4,440		$	1,858		$	4,440
Accounts receivable, net of allowance for doubtful accounts of $26 and $85, respectively		10,322			11,372
Accounts receivable, net of allowance for doubtful accounts of $31 and $85, respectively								9,993			11,372
Unbilled receivables		5,275			8,995			6,306			8,995
Inventories		953			680			1,057			680
Prepaid and other assets		4,077			4,472			6,209			4,472
Current assets related to discontinued operations		27			15			17			15
Total current assets		24,579			29,974			25,440			29,974

Property and equipment:
Buildings and land		20,642			20,631			24,048			20,631
Equipment		22,531			22,131			22,956			22,131
Vehicles		449			443			439			443
Leasehold improvements		23			23			23			23
Office furniture and equipment		1,316			1,316			1,320			1,316
Construction-in-progress		2,849			2,997			600			2,997
Total property and equipment		47,810			47,541			49,386			47,541
Less accumulated depreciation		(29,167	)		(28,932	)		(29,871	)		(28,932	)
Net property and equipment		18,643			18,609			19,515			18,609

Property and equipment related to discontinued operations		81			81			81			81

Operating lease right-of-use assets		2,347			2,460			2,087			2,460

Intangibles and other long term assets:
Permits		9,486			9,476			9,558			9,476
Other intangible assets - net		852			894			719			894
Finite risk sinking fund (restricted cash)		11,482			11,471			11,540			11,471
Deferred tax assets		4,263			3,527			3,801			3,527
Other assets		443			809			448			809
Total assets	$	72,176		$	77,301		$	73,189		$	77,301

The accompanying notes are an integral part of these consolidated financial statements.

PERMA-FIX ENVIRONMENTAL SERVICES, INC.

Consolidated Balance Sheets, Continued

March 31, December 31
2022 2021
(Amounts in Thousands, Except for Share and per Share Amounts) (Unaudited) (Audited)

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable $ 10,329 $ 11,975
Accrued expenses 5,537 5,078
Disposal/transportation accrual 1,162 1,065
Deferred revenue 2,707 5,580
Accrued closure costs - current 547 578
Current portion of long-term debt 384 393
Current portion of operating lease liabilities 416 406
Current portion of finance lease liabilities 354 333
Current liabilities related to discontinued operations 802 506
Total current liabilities 22,238 25,914

Accrued closure costs 6,706 6,613
Long-term debt, less current portion 491 600
Long-term operating lease liabilities, less current portion 1,921 2,029
Long-term finance lease liabilities, less current portion 920 884
Long-term liabilities related to discontinued operations 408 677
Total long-term liabilities 10,446 10,803

Total liabilities 32,684 36,717

Commitments and Contingencies (Note 9 ) — —

Stockholders’ Equity:
Preferred Stock, $.001 par value; 2,000,000 shares authorized, 0 shares issued and outstanding — —
Common Stock, $.001 par value; 30,000,000 shares authorized; 13,242,072 and 13,222,552 shares issued, respectively; 13,234,430 and 13,214,910 shares outstanding, respectively 13 13
Additional paid-in capital 114,532 114,307
Accumulated deficit (74,963 ) (73,620 )
Accumulated other comprehensive loss (2 ) (28 )
Less Common Stock in treasury, at cost; 7,642 shares (88 ) (88 )
Total stockholders’ equity 39,492 40,584

Total liabilities and stockholders’ equity $ 72,176 $ 77,301
September 30, December 31
2022 2021
(Amounts in Thousands, Except for Share and per Share Amounts) (Unaudited) (Audited)

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable $ 10,370 $ 11,975
Accrued expenses 6,436 5,078
Disposal/transportation accrual 1,291 1,065
Deferred revenue 3,145 5,580
Accrued closure costs - current 712 578
Current portion of long-term debt 469 393
Current portion of operating lease liabilities 431 406
Current portion of finance lease liabilities 154 333
Current liabilities related to discontinued operations 927 506
Total current liabilities 23,935 25,914

Accrued closure costs 7,306 6,613
Long-term debt, less current portion 681 600
Long-term operating lease liabilities, less current portion 1,673 2,029
Long-term finance lease liabilities, less current portion 357 884
Long-term liabilities related to discontinued operations 267 677
Total long-term liabilities 10,284 10,803

Total liabilities 34,219 36,717

Commitments and Contingencies (Note 9 ) - -

Stockholders’ Equity:
Preferred Stock, $.001 par value; 2,000,000 shares authorized,no shares issued and outstanding — —
Common Stock, $.001 par value; 30,000,000 shares authorized; 13,305,750 and 13,222,552 shares issued, respectively;13,298,108 and 13,214,910 shares outstanding, respectively 13 13
Additional paid-in capital 114,993 114,307
Accumulated deficit (75,744 ) (73,620 )
Accumulated other comprehensive loss (204 ) (28 )
Less Common Stock in treasury, at cost; 7,642 shares (88 ) (88 )
Total stockholders’ equity 38,970 40,584

Total liabilities and stockholders’ equity $ 73,189 $ 77,301

The accompanying notes are an integral part of these consolidated financial statements.

2
PERMA-FIX ENVIRONMENTAL SERVICES, INC.
Consolidated Statements of Operations
(Unaudited)

(Amounts in Thousands, Except for Per Share Amounts) 2022 2021 2022 2021 2022 2021
Three Months Ended Nine Months Ended

Three Months Ended
March 31,
September 30, September 30,
(Amounts in Thousands, Except for Per Share Amounts) 2022 2021 2022 2021 2022 2021

Revenues $ 15,915 $ 23,133
Net revenues $ 18,472 $ 15,797 $ 53,842 $ 55,075
Cost of goods sold 14,279 20,777 15,402 13,573 46,252 49,529
Gross profit 1,636 2,356 3,070 2,224 7,590 5,546

Selling, general and administrative expenses 3,422 3,205 3,929 3,348 11,035 9,550
Research and development 96 150 69 243 245 538
Loss on disposal of property and equipment 1 — — 1 1 1
Loss from operations (1,883 ) (999 ) (928 ) (1,368 ) (3,691 ) (4,543 )

Other income (expense):
Interest income 11 18 29 2 69 23
Interest expense (35 ) (67 ) (47 ) (77 ) (123 ) (209 )
Interest expense-financing fees (13 ) (8 ) (16 ) (11 ) (44 ) (28 )
Other (2 ) 1
Loss from continuing operations before taxes (1,922 ) (1,055 )
Income tax benefit (673 ) (17 )
Loss from continuing operations, net of taxes (1,249 ) (1,038 )
Other (Note 13) 1,965 (1 ) 1,960 —
Gain on extinguishment of debt — — — 5,381
Income (loss) from continuing operations before taxes 1,003 (1,455 ) (1,829 ) 624
Income tax expense (benefit) 179 (2,836 ) (147 ) (2,840 )
Income (loss) from continuing operations, net of taxes 824 1,381 (1,682 ) 3,464

Loss from discontinued operations (net of taxes) (Note 10) (94 ) (115 )
Net loss (1,343 ) (1,153 )
Loss from discontinued operations, net of taxes (Note 10) (160 ) (43 ) (442 ) (285 )
Net income (loss) 664 1,338 (2,124 ) 3,179

Net loss attributable to non-controlling interest — (30 ) — (64 ) — (123 )

Net loss attributable to Perma-Fix Environmental Services, Inc. common stockholders $ (1,343 ) $ (1,123 )
Net income (loss) attributable to Perma-Fix Environmental Services, Inc. common stockholders $ 664 $ 1,402 $ (2,124 ) $ 3,302

Net loss per common share attributable to Perma-Fix Environmental Services, Inc. stockholders - basic and diluted:
Net income (loss) per common share attributable to Perma-Fix Environmental Services, Inc. stockholders - basic:
Continuing operations $ (.09 ) $ (.08 ) $ .06 $ .12 $ (.13 ) $ .29
Discontinued operations (.01 ) (.01 ) (.01 ) (.01 ) (.03 ) (.02 )
Net loss per common share $ (.10 ) $ (.09 )
Net income (loss) per common share $ .05 $ .11 $ (.16 ) $ .27

Number of common shares used in computing net loss per share:
Net income (loss) per common share attributable to Perma-Fix Environmental Services, Inc. stockholders - diluted:
Continuing operations $ .06 $ .12 $ (.13 ) $ .29
Discontinued operations (.01 ) (.01 ) (.03 ) (.02 )
Net income (loss) per common share $ .05 $ .11 $ (.16 ) $ .27

Number of common shares used in computing net income (loss) per share:
Basic 13,234 12,165 13,297 12,198 13,265 12,181
Diluted 13,234 12,165 13,447 12,406 13,265 12,416
The accompanying notes are an integral part of these ~~condensed~~ consolidated financial statements.
3

PERMA-FIX ENVIRONMENTAL SERVICES, INC.
Consolidated Statements of Comprehensive ~~Loss~~Income (Loss)
(Unaudited)

(Amounts in Thousands) 2022 2021

Three Months Ended
March 31,

(Amounts in Thousands) 2022 2021

Net loss $ (1,343 ) $ (1,153 )
Other comprehensive income:
Foreign currency translation gain 26 20
Total other comprehensive income 26 20

Comprehensive loss (1,317 ) (1,133 )
Comprehensive loss attributable to non-controlling interest — (30 )
Comprehensive loss attributable to Perma-Fix Environmental Services, Inc. stockholders $ (1,317 ) $ (1,103 )
(Amounts in Thousands) 2022 2021 2022 2021
Three Months Ended Nine Months Ended
September 30, September 30,
(Amounts in Thousands) 2022 2021 2022 2021

Net income (loss) $ 664 $ 1,338 $ (2,124 ) $ 3,179
Other comprehensive (loss) income:
Foreign currency translation adjustment (135 ) (22 ) (176 ) 18

Comprehensive income (loss) 529 1,316 (2,300 ) 3,197
Comprehensive loss attributable to non-controlling interest — (64 ) — (123 )
Comprehensive income (loss) attributable to Perma-Fix Environmental Services, Inc. stockholders $ 529 $ 1,380 $ (2,300 ) $ 3,320
Comprehensive income (loss) attributable to Perma-Fix Environmental Services, Inc. stockholders $ 529 $ 1,380 $ (2,300 ) $ 3,320
The accompanying notes are an integral part of these ~~condensed~~ consolidated financial statements.
4
PERMA-FIX ENVIRONMENTAL SERVICES, INC
Consolidated Statement of Stockholders’ Equity
(Unaudited)
(Amounts in thousands, except for share amounts)
Shares Amount Capital Treasury Loss Subsidiary Deficit Equity
Common Stock Additional Paid-In Common Stock Held In Accumulated Other Comprehensive Non-controlling Interest in Accumulated Total Stockholders’
Shares Amount Capital Treasury Loss Subsidiary Deficit Equity

Balance at December 31, 2021 13,222,552 $ 13 $ 114,307 $ (88 ) $ (28 ) $ — $ (73,620 ) $ 40,584
Net loss — — — — — — (1,343 ) (1,343 )
Foreign currency translation — — — — 26 — — 26
Issuance of Common Stock for services 19,520 — 123 — — — — 123
Stock-Based Compensation — — 102 — — — — 102
Balance at March 31, 2022 13,242,072 $ 13 $ 114,532 $ (88 ) $ (2 ) $ — $ (74,963 ) $ 39,492

Balance at December 31, 2020 12,161,539 $ 12 $ 108,931 $ (88 ) $ (207 ) $ (1,742 ) $ (74,455 ) $ 32,451
Net loss — — — — — (30 ) (1,123 ) (1,153 )
Foreign currency translation — — — — 20 — — 20
Issuance of Common Stock for services 11,837 — 79 —        —       — — 79
Stock-Based Compensation — — 45 — — — — 45
Balance at March 31, 2021 12,173,376 $ 12 $ 109,055 $ (88 ) $ (187 ) $ (1,772 ) $ (75,578 ) $ 31,442
Shares Amount Capital Treasury Loss Subsidiary Deficit Equity
Additional Common Stock Accumulated Other Non-controlling Total
Common Stock Paid-In Held In Comprehensive Interest in Accumulated Stockholders’
Shares Amount Capital Treasury Loss Subsidiary Deficit Equity
Balance at December 31, 2021 13,222,552 $ 13 $ 114,307 $ (88 ) - $       (28 ) $         — $ (73,620 ) $ 40,584
Net loss — — — — — — (1,343 ) (1,343 )
Foreign currency translation — — — — - 26 — — 26
Issuance of Common Stock for services 19,520 — 123 — - — — — 123
Stock-Based Compensation — — 102 — - — — — 102
Balance at March 31, 2022 13,242,072 $ 13 $ 114,532 $ (88 ) - $ (2 ) $ — $ (74,963 ) $ 39,492
Net loss — — — — - — — (1,445 ) (1,445 )
Foreign currency translation — — — — - (67 ) — — (67 )
Issuance of Common Stock upon exercise of options (cashless) 16,526 — — — - — — — —
Issuance of Common Stock for services 21,667 — 120 — - — — — 120
Stock-Based Compensation — — 103 — - — — — 103
Balance at June 30, 2022 13,280,265 $ 13 $ 114,755 $ (88 ) - $ (69 ) $ — $ (76,408 ) $ 38,203
Net income — — — — - — — 664 664
Foreign currency translation — — — — - (135 ) — — (135 )
Issuance of Common Stock upon exercise of options 2,400 — 13 — - — — — 13
Issuance of Common Stock for services 23,085 — 120 — - — — — 120
Stock-Based Compensation — — 105 — - — — — 105
Balance at September 30, 2022 13,305,750 $ 13 $ 114,993 $ (88 ) - $ (204 ) $ — $ (75,744 ) $ 38,970
The accompanying notes are an integral part of these ~~condensed~~ consolidated financial statements.

5

PERMA-FIX ENVIRONMENTAL SERVICES, INC
Consolidated Statement of Stockholders’ Equity, Continued
(Unaudited)
(Amounts in thousands, except for share amounts)
Shares Amount Capital Treasury scriptions Loss Subsidiary Deficit Equity
Common Stock Additional Paid-In Common Stock Held In Stock Sub- Accumulated
Other Comprehensive Non-controlling Interest in Accumulated Total Stockholders’
Shares Amount Capital Treasury scriptions Loss Subsidiary Deficit Equity
Balance at December 31, 2020 12,161,539 $ 12 $ 108,931 $ (88 ) $ — $ (207 ) $ (1,742 ) $ (74,455 ) $ 32,451
Net loss — — — — — — (30 ) (1,123 ) (1,153 )
Foreign currency translation — — — — — 20 — — 20
Issuance of Common Stock for services 11,837 — 79 — — — — — 79
Stock-Based Compensation — — 45 — — — — — 45
Balance at March 31, 2021 12,173,376 $ 12 $ 109,055 $ (88 ) $ — $ (187 ) $ (1,772 ) $ (75,578 ) $ 31,442
Net (loss) income — — — — — — (29 ) 3,023 2,994
Foreign currency translation — — — — — 20 — — 20
Issuance of Common Stock upon exercise of options 290 — — — — — — — —
Issuance of Common Stock upon exercise of options (cashless) 290 — — — — — — — —
Issuance of Common Stock for services 14,590 — 109 — — — — — 109
Stock-Based Compensation — — 42 — — — — — 42
Balance at June 30, 2021 12,188,256 $ 12 $ 109,206 $ (88 ) $ — $ (167 ) $ (1,801 ) $ (72,555 ) $ 34,607
Net (loss) income — — — — — — (64 ) 1,402 1,338
Foreign currency translation — — — — — (22 ) — — (22 )
Issuance of Common Stock for services 16,009 — 116 — — — — — 116
Sale of Common Stock 100,000 — 570 ⁽¹⁾ — — — — — 570
Stock Subscriptions — — — — 4,387 ⁽²⁾ — — — 4,387
Stock-Based Compensation — — 62 — — — — — 62
Balance at September 30, 2021 12,304,265 $ 12 $ 109,954 $ (88 ) $ 4,387 $ (189 ) $ (1,865 ) $ (71,153 ) $ 41,058
(1) Net of offering costs incurred of approximately $50.
(2) Net of stock subscription receivables of $744 and offering costs incurred of approximately $449.
The accompanying notes are an integral part of these consolidated financial statements.
6
PERMA-FIX ENVIRONMENTAL SERVICES, INC.
Consolidated Statements of Cash Flows
(Unaudited)

(Amounts in Thousands) 2022 2021 2022 2021
Three Months Ended Nine Months Ended
March 31, September 30,
(Amounts in Thousands) 2022 2021 2022 2021
Cash flows from operating activities:
Net loss $ (1,343 ) $ (1,153 )
Net (loss) income $ (2,124 ) $ 3,179
Less: loss from discontinued operations, net of taxes (Note 10) (94 ) (115 ) (442 ) (285 )

Loss from continuing operations, net of taxes (1,249 ) (1,038 )
Adjustments to reconcile loss from continuing operations to cash provided by (used in) operating activities :
(Loss) income from continuing operations, net of taxes (1,682 ) 3,464
Adjustments to reconcile (loss) income from continuing operations to cash used in operating activities:
Depreciation and amortization 456 400 1,433 1,208
Interest on finance lease with purchase option — 2 — 7
Gain on extinguishment of debt — (5,381 )
Amortization of debt issuance costs 13 8 44 28
Deferred tax benefit (673 ) — (147 ) (2,931 )
Recovery of bad debt reserves (55 ) (17 )
Loss on disposal of plant, property, and equipment 1 —
(Recovery of) provision for bad debt reserves (47 ) 1
Loss on disposal of property and equipment 1 1
Issuance of common stock for services 123 79 363 304
Stock-based compensation 102 45 310 149
Changes in operating assets and liabilities of continuing operations:
Changes in operating assets and liabilities of continuing operations
Accounts receivable 1,105 (10,445 ) 1,426 (2,158 )
Unbilled receivables 3,720 5,224 2,689 8,757
Prepaid expenses, inventories and other assets 1,097 557 829 1,700
Accounts payable, accrued expenses and unearned revenue (4,492 ) (1,270 ) (5,553 ) (9,180 )
Cash provided by (used in) continuing operations 148 (6,455 )
Cash used in continuing operations (334 ) (4,031 )
Cash used in discontinued operations (142 ) (149 ) (559 ) (296 )
Cash provided by (used in) operating activities 6 (6,604 )
Cash used in operating activities (893 ) (4,327 )

Cash flows from investing activities:
Purchases of property and equipment (345 ) (361 ) (947 ) (1,132 )
Proceeds from sale of plant, property, and equipment 24 1
Proceeds from sale of property and equipment 25 1
Cash used in investing activities of continuing operations (321 ) (360 ) (922 ) (1,131 )

Cash flows from financing activities:
Repayments of revolving credit borrowings (17,494 ) (14,780 ) (54,414 ) (59,900 )
Borrowing on revolving credit 17,494 14,780 54,414 59,900
Proceeds from capital line 524 —
Principal repayments of finance lease liabilities (58 ) (114 ) (821 ) (281 )
Principal repayments of long term debt (110 ) (109 ) (375 ) (330 )
Payment of debt issuance costs (21 ) — (35 ) (40 )
Cash used in financing activities (189 ) (223 )
Proceeds from sale of Common Stock, net of Offering costs paid — 618
Proceeds from stock subscription, net of Offering costs paid — 4,816
Proceeds from issuance of common stock upon exercise of options 13 —
Cash (used in) provided by financing activities of continuing operations (694 ) 4,783

Effect of exchange rate changes on cash — (6 ) (4 ) (4 )

(Decrease) increase in cash and finite risk sinking fund (restricted cash) (504 ) (7,193 )
Decrease in cash and finite risk sinking fund (restricted cash) (2,513 ) (679 )
Cash and finite risk sinking fund (restricted cash) at beginning of period 15,911 19,370 15,911 19,370
Cash and finite risk sinking fund (restricted cash) at end of period $ 15,407 $ 12,177 $ 13,398 $ 18,691

Supplemental disclosure:
Interest paid $ 34 $ 54 $ 125 $ 163
Income taxes paid 6 — 6 15
Non-cash investing and financing activities:
Equipment purchase subject to finance lease 114 — 114 319
Equipment purchase subject to financing — 29 — 29
The accompanying notes are an integral part of these ~~condensed~~ consolidated financial statements.
67

PERMA-FIX ENVIRONMENTAL SERVICES, INC.
Notes to Consolidated Financial Statements
~~March 31,~~September 30, 2022
(Unaudited)
Reference is made herein to the notes to consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2021.

1. ~~Basis of Presentation~~
1. Basis of Presentation

The consolidated financial statements included herein have been prepared by the Company (which may be referred to as we, us or our), without an audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“the Commission”). Certain information and note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) have been condensed or omitted pursuant to such rules and regulations, although the Company believes the disclosures which are made are adequate to make the information presented not misleading. Further, the consolidated financial statements reflect, in the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position and results of operations as of and for the periods indicated. The results of operations for the ~~three~~nine months ended ~~March 31,~~September 30, 2022 are not necessarily indicative of results to be expected for the fiscal year ending December 31, 2022.

The Company suggests that these consolidated financial statements be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021.

The consolidated financial statements include the accounts of our wholly-owned subsidiaries and the account of a variable interest entity (“VIE”), Perma-Fix ERRG, for which we are the primary beneficiary (See “Note 1315 - VIE” for a discussion of this VIE). The consolidated financial statements for 2021 also included the accounts of the Company’s majority-owned Polish subsidiary, Perma-Fix Medical S.A (“PFM Poland”) and PFM Poland’s wholly-owned subsidiary, Perma-Fix Medical Corporation (“PFMC”), which comprised of the Company’s Medical Segment. As previously discussed, the Company made the strategic decision to cease all research and development (“R&D”) activities under the Medical Segment and sold 100% of its interest in PFM Poland in December 2021. As a condition ~~precent~~precedent to the sale of PFM Poland, the Company acquired PFMC after its conversion to a Delaware limited liability company. As a result of the sale of PFM Poland, the Company deconsolidated PFM Poland from its consolidated financial statements in December 2021. The Company’s Medical Segment had not generated any revenue.

Information for the Medical Segment is presented for the quarter ~~ending March 31,~~and nine months ended September 30, 2021. The Medical Segment was disposed of as of December 31, 2021 and is not relevant for the quarter ~~ending March 31,~~and nine month ended September 30, 2022. Prior period segment information is not required to be restated for the disposal of the segment.

2. ~~Summary of Significant Accounting Policies~~
2. Summary of Significant Accounting Policies
Our accounting policies are as set forth in the notes to the December 31, 2021 consolidated financial statements referred to above.
7
Recently Adopted Accounting Standards

In May 2021, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2021-04, “Earnings Per Share (Topic 206), Debt-Modifications and Extinguishments (Subtopic 470-50), Compensation-Stock Compensation (Topic 718), and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40): Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options (a consensus of the FASB Emerging Issues Task Force).” ASU 2021-04 addresses issuer’s accounting for certain modifications or exchanges of freestanding equity-classified written call options. This ASU is effective for all entities, for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted. The adoption of this ASU by the Company effective January 1, 2022 did not have a material impact on its financial statements.
8
In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting,” which provides optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships and other transactions affected by the discontinuation of the London Interbank Offered Rate (“LIBOR”) or by another reference rate expected to be discontinued because of reference rate reform. The guidance was effective beginning March 12, 2020 and can be applied prospectively through December 31, 2022. In January 2021, the FASB issued ASU No. 2021-01, “Reference Rate Reform (Topic 848): Scope,” which clarified the scope and application of the original guidance. The Company has determined that only its obligations under its credit facility are impacted by these ASUs at this time. During the third quarter of 2022, the Company entered into an amendment dated August 29, 2022 to its loan agreement which replaced the LIBOR option with the Secured Overnight Finance Rate (“SOFR”) option under its credit facility. The adoption of these ASUs by the Company during the third quarter of 2022 did not have a material impact to its financial statements (see “Note 8 – Long Term Debt” for a discuss of the Company’s credit facility and the amendment dated August 29, 2022).

Recently Issued Accounting Standards – Not Yet Adopted

In June 2016, the FASB issued ASU No. 2016-13, “Credit Losses (Topic 326) - Measurement of Credit Losses on Financial Instruments,” and various subsequent amendments to the initial guidance (collectively, “Topic 326”). Topic 326 introduces an approach, based on expected losses, to estimate credit losses on certain types of financial instruments and modifies the impairment model for available-for-sale debt securities. The new approach to estimating credit losses (referred to as the current expected credit losses model) applies to most financial assets measured at amortized cost and certain other instruments, including trade and other receivables and loans. Entities are required to apply the standard’s provisions as a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is adopted. In November 2019, FASB issued ASU 2019-10, “Financial Instruments – Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842),” which defers the effective date of ASU 2016-13 for public companies that are considered smaller reporting companies (“SRC”) as defined by the Commission to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. These ASUs are effective January 1, 2023 for the Company as an SRC. Under new guidance issued by the Commission in March 2020, the Company ~~continues~~continued to qualify as a ~~smaller reporting company~~SRC but became an accelerated filer ~~starting with~~for its 2021 Form 10-K and ~~all~~its 2022 quarterly 10-Q filings. The Company will remain a SRC but will become a non-accelerated filer for its 2022 Form 10-K and subsequent filings. The Company is currently evaluating the impact of these ASU on its consolidated financial ~~statements.~~
~~In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform (Topic 848): Facilitation~~statements; however, based on historical credit losses and as a significant amount of the Effects of Reference Rate Reform on Financial Reporting,” which provides optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships and other transactions affected by the discontinuation of the London Interbank Offered Rate (“LIBOR”) or by another reference rate expected to be discontinued because of reference rate reform. The guidance was effective beginning March 12, 2020 and can be applied prospectively through December 31, 2022. In January 2021, the FASB issued ASU No. 2021-01, “Reference Rate Reform (Topic 848): Scope,” which clarified the scope and application of the original guidance. The Company plans to adopt both ASUs when LIBOR is discontinued. The Company is currently evaluating the impact of the new ASUs on its condensed consolidated financial statements. As of the date of this report,Company’s receivables are generated from government entities, the Company ~~has determined that only its obligations under~~does not expect the ~~credit facility as described in “Note 8 – Long Term Debt would be impacted by~~adoption of these ~~ASUs. The~~ASUs to have a material impact to the Company’s ~~obligations under its credit facility permit for payment of annual rate of interests on its obligations using prime rate or LIBOR.~~financial statements.

In August 2020, the FASB issued ASU No. 2020-06, “Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity.” ASU 2020-06 simplifies the accounting for convertible instruments by removing major separation models and removing certain settlement condition qualifiers for the derivatives scope exception for contracts in an entity’s own equity, and simplifies the related diluted net income per share calculation for both Subtopics. ASU 2020-06 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2023, for the Company as an SRC. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company is currently evaluating the impact of this ASU on its consolidated financial statements and disclosures.

89

3. ~~Revenue~~
3. Revenue
Disaggregation of Revenue

In general, the Company’s business segmentation is aligned according to the nature and economic characteristics of our services and provides meaningful disaggregation of each business segment’s results of operations. The nature of the Company’s performance obligations within our Treatment and Services Segments ~~results~~result in the recognition of our revenue primarily over time. The following tables present further disaggregation of our revenues by different categories for our Services and Treatment Segments:
Schedule Ofof Disaggregation Ofof Revenue
Revenue by Contract Type
(In thousands) Three Months Ended Three Months Ended Three Months Ended Three Months Ended
March 31, 2022 March 31, 2021 September 30, 2022 September 30, 2021
Treatment Services Total Treatment Services Total Treatment Services Total Treatment Services Total
Fixed price $ 7,479 $ 5,761 $ 13,240 $ 7,495 $ 2,581 $ 10,076 $ 8,877 $ 6,892 $ 15,769 $ 8,893 $ 3,031 $ 11,924
Time and materials — 2,675 2,675 — 13,057 13,057 — 2,703 2,703 — 3,873 3,873
Total $ 7,479 $ 8,436 $ 15,915 $ 7,495 $ 15,638 $ 23,133 $ 8,877 $ 9,595 $ 18,472 $ 8,893 $ 6,904 $ 15,797

Revenue by generator
(In thousands) Three Months Ended Three Months Ended
March 31, 2022 March 31, 2021
Treatment Services Total Treatment Services Total
Domestic government $ 5,815 $ 8,245 $ 14,060 $ 4,598 $ 12,661 $ 17,259
Domestic commercial 1,436 162 1,598 2,265 590 2,855
Foreign government 92 6 98 534 2,364 2,898
Foreign commercial 136 23 159 98 23 121
Total $ 7,479 $ 8,436 $ 15,915 $ 7,495 $ 15,638 $ 23,133
Revenue by Contract Type
(In thousands) Nine Months Ended Nine Months Ended
September 30, 2022 September 30, 2021
Treatment Services Total Treatment Services Total
Fixed price $ 24,749 $ 20,569 $ 45,318 $ 24,094 $ 7,094 $ 31,188
Time and materials — 8,524 8,524 — 23,887 23,887
Total $ 24,749 $ 29,093 $ 53,842 $ 24,094 $ 30,981 $ 55,075
Revenue by generator
(In thousands) Three Months Ended Three Months Ended
September 30, 2022 September 30, 2021
Treatment Services Total Treatment Services Total
Domestic government $ 5,728 $ 9,264 $ 14,992 $ 6,725 $ 4,552 $ 11,277
Domestic commercial 2,806 313 3,119 1,956 399 2,355
Foreign government 287 — 287 36 1,931 1,967
Foreign commercial 56 18 74 176 22 198
Total $ 8,877 $ 9,595 $ 18,472 $ 8,893 $ 6,904 $ 15,797
Revenue by generator
(In thousands) Nine Months Ended Nine Months Ended
September 30, 2022 September 30, 2021
Treatment Services Total Treatment Services Total
Domestic government $ 17,786 $ 28,158 $ 45,944 $ 16,962 $ 24,172 $ 41,134
Domestic commercial 6,045 859 6,904 6,284 1,185 7,469
Foreign government 532 12 544 577 5,556 6,133
Foreign commercial 386 64 450 271 68 339
Total $ 24,749 $ 29,093 $ 53,842 $ 24,094 $ 30,981 $ 55,075
Contract ~~Liabilities~~Balances

The Company’s contract liabilities consist of deferred revenues which represent advance payment from customers in advance of the completion of our performance obligation. The following table represents changes in our contract liabilities balances:
Schedule Ofof Contract Liabilities
Year-to-date Year-to-date Year-to-date Year-to-date
(In thousands) March 31, 2022 December 31, 2021 Change ($) Change (%) September 30, 2022 December 31, 2021 Change ($) Change (%)
Contract liabilities
Deferred revenue $ 2,707 $ 5,580 $ (2,873 ) (51.5 )% $ 3,145 $ 5,580 $ (2,435 ) (43.6 )%

The decrease was attributed primarily ~~due~~ to revenue recognized in connection with a Services Segment contract. ~~The decrease was also attributed to more processing of Treatment Segment’s backlog due to continued delays in waste receipts from certain customers from the impact of COVID-19.~~
10

During the three and nine months ended ~~March 31,~~September 30, 2022, ~~and 2021,~~ the Company recognized revenue of $~~3,521,000~~494,000 and $~~4,311,000~~6,138,000, respectively, related to untreated waste that was in the Company’s control as of the beginning of ~~each respective~~the year. ~~Revenue~~During the three and nine months ended September 30, 2021, the Company recognized revenue of $561,000 and $6,635,000, respectively, related to untreated waste that was in the Company’s control as of the beginning of the year. All revenue recognized in each period related to performance obligations satisfied within the respective period.

Variable Consideration
The Company’s revenue for the three months ended September 30, 2022 included approximately $384,000 recognized within the Company’s Treatment Segment and $148,000 recognized within the Company’s Services Segment that resulted from cumulative catch-up adjustments in transaction price from performance obligations satisfied or partially satisfied in the prior periods that had been constrained. During the three months ended September 30, 2021, the Company recognized approximately $1,286,000 in revenue from a request for equitable adjustment (“REA”) in its Treatment Segment that resulted in cumulative catch-up adjustment in transaction price that had been constrained in prior period.
Remaining Performance Obligations

The Company applies the practical expedient in paragraph 606-10-50-14 and does not disclose information about remaining performance obligations that have original expected durations of one year or less.

Within our Services Segment, there are service contracts which provide that the Company has a right to consideration from a customer in an amount that corresponds directly with the value to the customer of our performance completed to date. For those contracts, the Company has utilized the practical expedient in ASC 606-10-55-18, which allows the Company to recognize revenue in the amount for which we have the right to invoice; accordingly, the Company does not disclose the value of remaining performance obligations for those contracts.

The Company’s contracts and subcontracts relating to activities at governmental sites generally allow for termination for convenience at any time at the government’s option without payment of a substantial penalty. The Company does not disclose remaining performance obligations on these contracts.

9
4. Leases
4. ~~Leases~~
At the inception of an arrangement, the Company determines if an arrangement is, or contains, a lease based on facts and circumstances present in that arrangement. Lease classifications, recognition, and measurement are then determined at the lease commencement date.

The Company’s operating lease right-of-use (“ROU”) assets and operating lease liabilities represent primarily leases for office and warehouse spaces used to conduct our business. Finance leases consist primarily of processing and transport equipment used by our facilities’ operations.

11
The components of lease cost for the Company’s leases for the three and nine months ended September 30, 2022 and 2021 were as follows (in thousands):
Schedule Ofof Components Ofof Lease Cost
2022 2021 2022 2021 2022 2021
Three Months Ended Three Months Ended Nine Months Ended
March 31, September 30, September 30,
2022 2021 2022 2021 2022 2021
Operating Lease:

Operating Leases:
Lease cost $ 157 $ 111 $ 157 $ 115 $ 471 $ 341

Finance Leases:
Amortization of ROU assets 47 59 42 53 133 170
Interest on lease liability 11 19 9 50 30 85
Finance leases 58 78
Finance Leases 51 103 163 255

Short-term lease rent expense 3 3 — 4 7 10

Total lease cost $ 218 $ 192 $ 208 $ 222 $ 641 $ 606

The weighted average remaining lease term and the weighted average discount rate for operating and finance leases at ~~March 31,~~September 30, 2022 were:
Schedule Ofof Weighted Average Lease
Operating Leases Finance Leases Operating Leases Finance Leases
Weighted average remaining lease terms (years) 6.7 4.0 6.4 3.4

Weighted average discount rate 7.6 % 6.1 % 7.8 % 5.3 %

~~The weighted average remaining lease term and the weighted average discount rate for operating and finance leases at March 31, 2021 were:~~
Operating Leases Finance Leases
Weighted average remaining lease terms (years) 7.8 3.4

Weighted average discount rate 7.8 % 6.8 %
10
The following table reconciles the undiscounted cash flows for the operating and finance leases at ~~March 31,~~September 30, 2022 to the operating and finance lease liabilities recorded on the balance sheet (in thousands):
Schedule Ofof Operating ~~And~~and Finance Lease Liability Maturity
Operating Leases Finance Leases Operating Leases Finance Leases
2022 (Remaining) $ 433 $ 315
2022 (Remaining ) $ 144 $ 47
2023 560 327 556 174
2024 419 323 416 170
2025 328 300 324 147
2026 304 171 301 18
2027 and thereafter 955 20 942 —
Total undiscounted lease payments 2,999 1,456 2,683 556
Less: Imputed interest (662 ) (182 ) (579 ) (45 )
Present value of lease payments $ 2,337 $ 1,274 $ 2,104 $ 511

Current portion of operating lease obligations $ 416 $ — $ 431 $ —
Long-term operating lease obligations, less current portion $ 1,921 $ — $ 1,673 $ —
Current portion of finance lease obligations $ — $ 354 $ — $ 154
Long-term finance lease obligations, less current portion $ — $ 920 $ — $ 357

12
Supplemental cash flow and other information related to our leases were as follows for the three and nine months ended September 30, 2022 and 2021 (in thousands):
Schedule Ofof Supplemental Cash Flow ~~And~~and Other Information Related Toto Leases
2022 2021
Three Months Ended
March 31,
2022 2021
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flow from operating leases $ 143 $ 101
Operating cash flow from finance leases $ 11 $ 19
Financing cash flow from finance leases $ 58 $ 114

ROU assets obtained in exchange for lease obligations for:
Finance liabilities $ 147 $ —
Operating liabilities $ — $ —
2022 2021 2022 2021
Three Months Ended Nine Months Ended
September 30, September 30,
2022 2021 2022 2021
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flow used in operating leases $ 144 $ 103 $ 430 $ 307
Operating cash flow used in finance leases $ 9 $ 50 $ 30 $ 85
Financing cash flow used in finance leases $ 103 $ 76 $ 821 $ 281

ROU assets obtained in exchange for lease obligations for:
Finance liabilities $ — $ 323 $ 147 $ 323
Operating liabilities $ — 184 $ — $ 350
Reduction to ROU assets resulting from reassessment for:
Finance liabilities $ — $ (364 ) $ — $ (364 )

5. ~~Intangible Assets~~
5. Intangible Assets

The following table summarizes information relating to the Company’s definite-lived intangible assets:
Schedule Ofof Definite Lived Intangible Assets
March 31, 2022 December 31, 2021

Weighted Average
Amortization
Gross Net Gross Net Weighted Average September 30, 2022 December 31, 2021
Period Carrying Accumulated Carrying Carrying Accumulated Carrying Amortization Period Gross Carrying Accumulated Net Carrying Gross Carrying Accumulated Net Carrying
(Years) Amount Amortization Amount Amount Amortization Amount (Years) Amount Amortization Amount Amount Amortization Amount
Other Intangibles (amount in thousands)
Patent 8.3 $ 787 $ (354 ) $ 433 $ 787 $ (351 ) $ 436 8.6 $ 744 $ (369 ) $ 375 $ 787 $ (351 ) $ 436
Software 3 606 (428 ) 178 592 (415 ) 177 3 636 (453 ) 183 592 (415 ) 177
Customer relationships 10 3,370 (3,129 ) 241 3,370 (3,089 ) 281 10 3,370 (3,209 ) 161 3,370 (3,089 ) 281
Total $ 4,763 $ (3,911 ) $ 852 $ 4,749 $ (3,855 ) $ 894 - $ 4,750 $ (4,031 ) $ 719 $ 4,749 $ (3,855 ) $ 894
The intangible assets noted above are amortized on a straight-line basis over their useful lives with the exception of customer relationships which are being amortized using an accelerated method.

11
The following table summarizes the expected amortization over the next five years for our definite-lived intangible assets:
Schedule Ofof Finite Lived Intangible Assets, Future Amortization Expense
Amount Amount
Year (In thousands) (In thousands)

2022 (Remaining) $ 164
2022(Remaining) $ 57
2023 178 187
2024 46 61
2025 11 11
2026 11 11

Amortization ~~expenses~~expense relating to the definite-lived intangible assets as discussed above ~~were~~was $~~56,000~~65,000 and $~~50,000~~176,000 for the three and nine months ended ~~March 31,~~September 30, 2022, respectively, and $51,000 and $152,000 for the three and nine months ended September 30, 2021, respectively.

6. ~~Capital Stock, Stock Plans, Warrants and Stock Based Compensation~~
6. Capital Stock, Stock Plans and Stock-Based Compensation

The Company has certain stock option plans under which it may award incentive stock options (“ISOs”) and/or non-qualified stock options (“NQSOs”) to employees, officers, outside directors, and outside consultants. No
13
On July 21, 2022, the Company issued a NQSO to each of the Company’s seven reelected outside directors for the purchase, under the Company’s 2003 Outside Directors Stock Plan (the “2003 Plan”), of up to 10,000 shares of the Company’s common stock, ~~options were~~par value $0.001 per share (the “Common Stock”). Dr. Louis Centofanti, the Company’s Executive Vice President (“EVP”) of Strategic Initiatives and also a member of the Company’s Board of Directors (the “Board”), was not eligible to receive an option under the 2003 Plan as an employee of the Company. Each NQSO granted inis for a contractual term of ten years with one-fourth vesting annually over a four-year period. The exercise price of the ~~first quarter~~NQSO is $5.15 per share, which was equal to the fair market value of ~~2022.~~the Company’s Common Stock the day preceding the grant date, pursuant to the 2003 Plan.
On July 21, 2022, the Company granted ISOs to certain employees for purchase under the Company’s 2017 Stock Option Plan, as amended (the “2017 Plan”), of up to an aggregate of 24,000 shares of the Common Stock. Each ISO granted is for a contractual term of six years with one-fifth vesting annually over a five-year period. The exercise price of the ISO was $5.34 per share, which was equal to the fair market value of the Company’s Common Stock on the date of grant.

The Company granted a NQSO to Robert Ferguson on July 27, 2017 from the Company’s 2017 Stock Option Plan (“2017 Plan”) for the purchase of up to 100,000 shares of the Company’s Common Stock (“Ferguson Stock Option”) in connection with his work as a consultant to the Company’s Test Bed Initiative (“TBI”) at our Perma-Fix Northwest Richland, Inc. (“PFNWR”) facility at an exercise price of $3.65 per share, which was the fair market value of the Company’s Common Stock on the date of grant. The term of the Ferguson Stock Option is seven years from the grant date. The vesting of the Ferguson Stock Option is subject to the achievement of three separate milestones by certain dates. The first milestone was met and the 10,000shares under the first milestone were issued to Robert Ferguson in May 2018. The Company had previously entered into amendments whereby the vesting dates for the second and third milestones for the purchase of up to 30,000 and 60,000 shares of the Company’s Common Stock were extended to December 31, 2021 and December 31, 2022, respectively. On January 20, 2022, the Company’s Compensation and Stock Option Committee (“Compensation Committee”) and the Board ~~of Directors (“Board”)~~ further amended the vesting dates of the second and third milestones to December 31, 2022 and December 31, 2023, respectively. This amendment was approved by the Compensation Committee and the Board to take effect December 31, 2021. The Company has not recognized compensation costs (fair value of approximately $289,000 at ~~March 31,~~September 30, 2022) for the remaining 90,000 Ferguson Stock Option under the remaining two milestones since achievement of the performance obligation under each of the two remaining milestones is uncertain at ~~March 31,~~September 30, 2022. All other terms of the Ferguson Stock Option remain unchanged. Upon Mr. Ferguson’s death, the remaining Ferguson Stock Options are now held by Mr. Ferguson’s estate.
The Company estimates fair value of stock options using the Black-Scholes valuation model. Assumptions used to estimate the fair value of stock options granted include the exercise price of the award, the expected term, the expected volatility of the Company’s stock over the option’s expected term, the risk-free interest rate over the option’s expected term, and the expected annual dividend yield. The fair value of the options granted as discussed above and the related assumptions used in the Black-Scholes option model used to value the options granted for the nine months ended September 30, 2022 were as follows:
Schedule of Stock Options Valuation Assumptions
Outside Director Stock Option Granted
Employee Stock Option Granted

Nine Months Ended September 30, 2022
Weighted-average fair value per share $ 3.61 $ 2.71
Risk-free interest rate ⁽¹⁾ 2.91 % 3.00 %
Expected volatility of stock ⁽²⁾ 55.04 % 55.72 %
Dividend yield None None
Expected option life ⁽³⁾ 10.0 years 5.0 years
⁽¹⁾ The risk-free interest rate is based on the U.S. Treasury yield in effect at the grant date over the expected term of the option.
⁽²⁾ The expected volatility is based on historical volatility from our traded Common Stock over the expected term of the option.
⁽³⁾ The expected option life is based on historical exercises and post-vesting data.
14
The following table summarizes stock-based compensation recognized for the three and nine months ended ~~March 31,~~September 30, 2022 and 2021 for our employee and director stock options.
Schedule of Share-based Compensation, Allocation of Recognized Period Costs
2022 2021 2022 2021 2022 2021
Three Months Ended Three Months Ended Nine Months Ended
Stock Options March 31, September 30, September 30,
2022 2021 2022 2021 2022 2021
Employee Stock Options $ 86,000 $ 33,000 $ 76,000 $ 34,000 $ 248,000 $ 100,000
Director Stock Options 16,000 12,000 29,000 28,000 62,000 49,000
Total $ 102,000 $ 45,000 $ 105,000 $ 62,000 $ 310,000 $ 149,000

At ~~March 31,~~September 30, 2022, the Company has approximately $~~1,287,000~~1,396,000 of total unrecognized compensation costs related to unvested options for employee and directors. The weighted average period over which the unrecognized compensation costs are expected to be recognized is approximately ~~4.1~~3.8 years.

12
The summary of the Company’s total ~~Stock Option Plans~~stock option plans as of ~~March 31,~~September 30, 2022 and ~~March 31,~~September 30, 2021, and changes during the periods then ended, are presented below. The Company’s ~~Plans consist~~plans consist/consisted of the 2010 Stock Option Plan, the 2017 Plan and the 2003 ~~Outside Directors Stock Plan (“2003 Plan”):~~Plan:
Schedule of Stock Options Roll Forward
Shares
Weighted Average
Exercise
Price

Weighted Average Remaining Contractual Term
(years)

Aggregate Intrinsic
Value ⁽³⁾

Options outstanding January 1, 2022 1,019,400 $ 4.91 —
Granted — $ —
Exercised — $ — $ —
Forfeited/expired — $ —
Options outstanding end of period ⁽¹⁾ 1,019,400 $ 4.91 3.8 $ 1,150,167
Options exercisable at March 31, 2022⁽¹⁾ 455,900 $ 3.92 2.5 $ 779,362
Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term (years) Aggregate Intrinsic Value ⁽³⁾
Options outstanding January 1, 2022 1,019,400 $ 4.91 -
Granted 94,000 $ 5.20
Exercised (52,400 ) $ 4.04 $ 97,856
Forfeited/expired (9,600 ) $ 5.50
Options outstanding end of period ⁽¹⁾ 1,051,400 $ 4.98 4.0 $ 492,939
Options exercisable at September 30, 2022⁽¹⁾ 453,900 $ 3.93 2.4 $ 354,709

Shares
Weighted Average
Exercise
Price

Weighted Average Remaining Contractual Term
(years)

Aggregate Intrinsic
Value ⁽³⁾

Options outstanding January 1, 2021 658,400 $ 3.87 —
Granted — —
Exercised — — $ —
Forfeited/expired — —
Options outstanding end of period ⁽²⁾ 658,400 $ 3.87 3.2 $ 2,279,267
Options exercisable at March 31, 2021⁽²⁾ 392,400 $ 4.08 3.4 $ 1,274,287
Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term (years) Aggregate Intrinsic Value ⁽³⁾
Options outstanding January 1, 2021 658,400 $ 3.87 -
Granted 76,000 $ 6.05
Exercised (500 ) $ 3.15 $ 2,175
Forfeited/expired (19,500 ) $ 6.75
Options outstanding end of period ⁽¹⁾ 714,400 $ 4.02 3.6 $ 1,888,695
Options exercisable at September 30, 2021 ⁽²⁾ 416,400 $ 3.91 2.9 $ 1,146,320

⁽¹⁾ Options with exercise prices ranging from $2.79 to $7.50
⁽²⁾ Options with exercise prices ranging from $2.79 to $7.29
⁽³⁾ The intrinsic value of a stock option is the amount by which the market value of the underlying stock exceeds the exercise ~~price of the option.~~price.
15

During the ~~three~~nine months ended ~~March 31,~~September 30, 2022, the Company issued a total of ~~19,520~~64,272 shares of its Common Stock under the 2003 Plan to its outside directors as compensation for serving on our Board. The Company has recorded approximately $~~120,000~~359,000 in compensation expenses (included in selling, general and administration (“SG&A”) expenses) in connection with the issuance of shares of its Common Stock to outside directors.
During the nine months ended September 30, 2022, the Company issued 16,526 shares of its Common Stock from a cashless exercise of an option for the purchase of 50,000 shares of the Company’s Common Stock at $3.97 per share. Additionally, the Company issued 2,400 shares of its Common Stock from the exercise of an option for the purchase of 2,400 shares of the Company’s Common Stock at $5.50 per share resulting in proceeds of approximately $13,000.

In connection with a $2,500,000 loan that the Company entered into with Mr. Robert Ferguson (the “Ferguson Loan”) on April 1, 2019, the Company issued a warrant to Mr. Ferguson for the purchase of up to 60,000 shares of our Common Stock at an exercise price of $3.51 per share. The warrant expires on April 1, 2024 and remains outstanding at ~~March 31,~~September 30, 2022. Upon Mr. Ferguson’s death, the warrant is now held by Mr. Ferguson’s estate. The Ferguson Loan was paid-in-full in December 2020.

13
7. Income (Loss) Per Share
7. ~~Loss Per Share~~

Basic ~~loss~~income (loss) per share is calculated based on the weighted-average number of outstanding common shares during the applicable period. Diluted ~~loss~~income (loss) per share is based on the weighted-average number of outstanding common shares plus the weighted-average number of potential outstanding common shares. In periods where they are anti-dilutive, such amounts are excluded from the calculations of dilutive ~~loss~~ earnings per ~~shares.~~share. The following table reconciles the ~~loss~~income (loss) and average share amounts used to compute both basic and diluted ~~loss~~income (loss) per share:
Schedule of Earning Per Share
2022 2021
(Amounts in Thousands, Except for Per Share Amounts) 2022 2021 2022 2021
Three Months Ended Three Months Ended Nine Months Ended
(Unaudited) September 30, September 30,
March 31, (Unaudited) (Unaudited)
(Amounts in Thousands, Except for Per Share Amounts) 2022 2021 2022 2021 2022 2021
Net loss attributable to Perma-Fix Environmental Services, Inc., common stockholders:
Loss from continuing operations, net of taxes $ (1,249 ) $ (1,038 )
Net income (loss) attributable to Perma-Fix Environmental Services, Inc., common stockholders:
Income (loss) from continuing operations, net of taxes $ 824 1,381 (1,682 ) 3,464
Net loss attributable to non-controlling interest — (30 ) — (64 ) — (123 )
Loss from continuing operations attributable to Perma-Fix Environmental Services, Inc. common stockholders (1,249 ) (1,008 )
Income (loss) from continuing operations attributable to Perma-Fix Environmental Services, Inc. common stockholders $ 824 $ 1,445 $ (1,682 ) $ 3,587
Income (loss) from continuing operations attributable to Perma-Fix Environmental Services, Inc. common stockholders $ 824 $ 1,445 $ (1,682 ) $ 3,587
Loss from discontinuing operations attributable to Perma-Fix Environmental Services, Inc. common stockholders (94 ) (115 ) (160 ) (43 ) (442 ) (285 )
Net loss attributable to Perma-Fix Environmental Services, Inc. common stockholders $ (1,343 ) $ (1,123 )
Net income (loss) attributable to Perma-Fix Environmental Services, Inc. common stockholders $ 664 $ 1,402 $ (2,124 ) $ 3,302

Basic loss per share attributable to Perma-Fix Environmental Services, Inc. common stockholders $ (.10 ) $ (.09 )
Basic income (loss) per share attributable to Perma-Fix Environmental Services, Inc. common stockholders $ .05 $ .11 $ (.16 ) $ .27

Diluted loss per share attributable to Perma-Fix Environmental Services, Inc. common stockholders $ (.10 ) $ (.09 )
Diluted income (loss) per share attributable to Perma-Fix Environmental Services, Inc. common stockholders $ .05 $ .11 $ (.16 ) $ .27

Weighted average shares outstanding:
Basic weighted average shares outstanding 13,234 12,165 13,297 12,198 13,265 12,181
Add: dilutive effect of stock options — — 131 183 — 206
Add: dilutive effect of warrants — —
Add: dilutive effect of warrant 19 25 — 29
Diluted weighted average shares outstanding 13,234 12,165 13,447 12,406 13,265 12,416

Potential shares excluded from above weighted average share calculations due to their anti-dilutive effect include:
Stock options 405 30 499 30 405 30
Warrant — — — — — —
16

8. Long Term Debt
8. ~~Long Term Debt~~
Long-term debt consists of the following:
Schedule of Long Term Debt
(Amounts in Thousands) March 31, 2022 December 31, 2021 September 30, 2022 December 31, 2021
Revolving Credit facility dated May 8, 2020, borrowings based upon eligible accounts receivable, subject to monthly borrowing base calculation, balance due on May 15, 2024. Effective interest rate for first quarter of 2022 was 0%. ⁽¹⁾ $ — $ —
Term Loan dated May 8, 2020, payable in equal monthly installments of principal, balance due on May 15, 2024. Effective interest rate for the first quarter of 2022 was 4.3%. ⁽¹⁾ 840 ⁽²⁾ 954 ⁽²⁾
Revolving Credit facility dated May 8, 2020, borrowings based upon eligible accounts receivable, subject to monthly borrowing base calculation, balance due on May 15, 2024. Effective interest rate for first nine month of 2022 was 0%. ⁽¹⁾ $ — $ —
Revolving Credit facility dated May 8, 2020, borrowings based upon eligible accounts receivable, subject to monthly borrowing base calculation, balance due on May 15, 2024. Effective interest rate for first nine month of 2022 was 0%. ⁽¹⁾ $ — $ —
Term Loan dated May 8, 2020, payable in equal monthly installments of principal, balance due on May 15, 2024. Effective interest rate for the first nine month of 2022 was 4.8%. ⁽¹⁾ 642 (2) 954 (2)
Capital Line dated May 4, 2021, payable in equal monthly installments of principal, balance due on May 15, 2024. Effective interest rate for the first nine month of 2022 was 5.3%. ⁽¹⁾ 480 —
Notes Payable to 2023 and 2025, annual interest rate of 5.6% and 9.1%. 35 39 28 39
Total debt 875 993 1,150 993
Less current portion of long-term debt 384 393 469 393
Long-term debt $ 491 $ 600 $ 681 $ 600
⁽¹⁾ Our revolving credit facility is collateralized by our accounts receivable and our term loan isand capital line are collateralized by our property, plant, and equipment.
⁽²⁾ Net of debt issuance costs of ($~~120,000~~104,000) and ($112,000) at ~~March 31,~~September 30, 2022 and December 31, 2021, respectively.

14
Revolving Credit, ~~and~~ Term Loan and Capital Line Agreement

The Company entered into a Second Amended and Restated Revolving Credit, Term Loan and Security Agreement, dated May 8, 2020 (“Loan Agreement”), with PNC National Association (“PNC”), acting as agent and lender. The Loan Agreement ~~provides~~provided the Company with the following credit facility with a maturity date of March 15, 2024: (a) up to $18,000,000 revolving credit (“revolving credit”) and (b) a term loan (“term loan”) of approximately $1,742,000, requiring monthly installments of $35,547. The maximum that the Company can borrow under the revolving credit is based on a percentage of eligible receivables (as defined) at any one time reduced by outstanding standby letters of credit and borrowing reductions that ~~our~~the Company’s lender may impose from time to time. The Loan Agreement, as amended (the “Amended Loan Agreement”), also provides a capital expenditure line of up to $1,000,000 with advances on the line, subject to certain limitations, permitted for up to twelve months starting May 4, 2021 (the “Borrowing Period”). Only interest is payable on advances during the Borrowing Period. At the end of the Borrowing Period, the total amount advanced under the line will amortize equally based on a five-year amortization schedule with principal payment due monthly plus interest. At the maturity date of the Amended Loan Agreement, ~~as amended,~~ any unpaid principal balance plus interest, if any, will become due. ~~No advance on~~Amount advanced under the capital line ~~has been made as~~totaled approximately $524,000 which requires monthly installments in principal of ~~March 31,~~approximately $8,700 plus interest, starting June 1, 2022. The advance was used to purchase the underlying asset under a previous finance lease.
17

On March 29, 2022, the Company entered into an amendment to its Amended Loan Agreement with its lender which provided, among other things, the following:

● waived the Company’s failure to meet the minimum quarterly fixed charge coverage ratio (“FCCR”) requirement for the fourth quarter of 2021;
● removes the quarterly FCCR testing requirement for the first quarter of 2022;
● reinstates the quarterly FCCR testing requirement starting for the second quarter of 2022 and revises the methodology to be used in calculating the FCCR for the quarters ending June 30, 2022, September 30, 2022, and December 31, 2022 (with no change to the minimum 1.15:1 ratio requirement for each quarter);
● requires maintenance of a minimum of ~~$3,000,000~~$3,000,000 in borrowing availability under the revolving credit until the minimum FCCR requirement for the quarter ended June 30, 2022 has been met and certified to the ~~lender;~~lender; and
● revises the annual rate used to calculate the Facility Fee (as defined in the Loan Agreement) on the revolving credit, with addition of the capital expenditure line, from 0.375% to 0.500%. Upon meeting the minimum FCCR requirement of 1.15:1 on a twelve ~~months~~month trailing basis, the Facility Fee rate of 0.375% will be reinstated.

In connection with the amendment, wethe Company paid PNC a fee of $15,000 which is being amortized over the remaining term of the Amended Loan Agreement ~~as amended,~~ as interest expense-financing fees.

~~Pursuant~~On August 2, 2022, the Company entered into an amendment to its Amended Loan Agreement with its lender which provided the following, among other things:
● waived the Company’s failure to meet the minimum quarterly FCCR requirement for the second quarter of 2022;
● removes the quarterly FCCR testing requirement for the third quarter of 2022;
● reinstates the quarterly FCCR testing requirement starting for the fourth quarter of 2022 and revises the methodology to be used in calculating the FCCR for the quarters ending December 31, 2022 and March 31, 2023 (with no change to the minimum 1.15:1 ratio requirement for each quarter);
● requires maintenance of a minimum of $3,000,000 in borrowing availability under the revolving credit until the minimum FCCR requirement for the quarter ended December 31, 2022 has been met and certified to the lender.
In connection with the amendment, the Company paid PNC a fee of $15,000 which is being amortized over the remaining term of the Amended Loan Agreement as ~~amended, payment of annual rate of~~ interest ~~due on the revolving credit is at prime (3.50% at March 31, 2022) plus~~ 2~~% or LIBOR plus~~ ~~3.00% and the term loan and the capital expenditure line at prime plus~~ ~~2.50% or LIBOR plus~~ ~~3.50%. Under the LIBOR option of interest payment, a LIBOR floor of~~ ~~0.75% applies in the event that LIBOR falls below~~ ~~0.75% at any point in time.~~
The Company may terminate its Loan Agreement, as amended, upon 90 days’ prior written notice upon payment in full of our obligations under the Loan Agreement. The Company has agreed to pay PNC 0.5% of the total financing if it pays off its obligations after May 7, 2021 but prior to or on May 7, 2022. No early termination fee will apply if the Company pays off its obligations under the Loan Agreement after May 7, 2022.
~~At March 31, 2022, the borrowing availability under the Company’s revolving credit was approximately $4,544,000~~ ~~based on our eligible receivables and includes a reduction in borrowing availability of approximately $3,020,000~~ ~~from outstanding standby letters of credit.~~expense-financing fees.

The Company’s credit facility under its Amended Loan Agreement ~~as amended,~~ with PNC contains certain financial covenants, along with customary representations and warranties. A breach of any of these financial covenants, unless waived by PNC, could result in a default under our credit facility allowing our lender to immediately require the repayment of all outstanding debt under our credit facility and terminate all commitments to extend further credit. The Company was not required to perform testing of the FCCR requirement in the first ~~quarter~~and third quarters of 2022 pursuant to the March 29, 2022 and August 2, 2022 amendments, respectively, as discussed above. The Company failed to meet its FCCR requirement in the second quarter of 2022; however, this non-compliance was waived by the Company’s lender pursuant to the August 2, 2022 amendment as discussed above. Other than the FCCR covenant discussion above, ~~otherwise, it~~the Company met all of its other financial covenant ~~requirements.~~requirements in the first, second and third quarters of 2022.
On August 29, 2022, the Company entered into an amendment to its Amended Loan Agreement with its lender which set forth certain revisions to the Amended Loan Agreement, with the amended terms set forth in a revised Loan Agreement. The new revisions to the Amended Loan Agreement (the “Revised Loan Agreement”), among other things, replace the LIBOR based interest rate benchmark with the SOFR and add certain additional anti-terrorism provisions to the covenants contained in the Amended Loan Agreement. As a result of this amendment, payment of annual rate of interest due on the revolving credit is at prime (6.25% at September 30, 2022) plus 2% or Term SOFR Rate (as defined in the Revised Loan Agreement) plus 3.00% plus an SOFR Adjustment applicable for an interest period selected by the Company and payment of annual rate of interest due on the term loan and the capital expenditure line is at prime plus 2.50% or Term SOFR Rate plus 3.50% plus an SOFR Adjustment applicable for an interest period selected by the Company. Pursuant to the Revised Loan Agreement, SOFR Adjustment rates of 0.10% and 0.15% are applicable for a one-month interest period and three-month period, respectively, that may be selected by the Company.

1518

9. ~~Commitments and Contingencies~~
After May 7, 2022, the Company may terminate its Revised Loan Agreement upon 90 days’ prior written notice upon payment in full of our obligations under the Revised Loan Agreement with no early termination fees.
At September 30, 2022, the borrowing availability under the Company’s revolving credit was approximately $4,548,000 based on our eligible receivables and is net of approximately $3,016,000 in outstanding standby letters of credit.
9. Commitments and Contingencies

Hazardous Waste

In connection with our waste management services, the Company processes hazardous, non-hazardous, low-level radioactive and mixed (containing both hazardous and ~~non-hazardous~~low-level radioactive) waste, which we transport to our own, or other, facilities for destruction or disposal. As a result of disposing of hazardous substances, in the event any cleanup is required at the disposal site, the Company could be a potentially responsible party for the costs of the cleanup notwithstanding any absence of fault on our part.

Legal Matters

In the normal course of conducting our business, we ~~are~~may be involved in various litigation. We are not a party to any litigation or governmental proceeding which our management believes could result in any judgments or fines against us that could would have a material adverse effect on our financial position, liquidity or results of future operations.

Tetra Tech EC, Inc. (“Tetra Tech”)

During July 2020, Tetra Tech EC, Inc. (“Tetra Tech”) filed a complaint in the United States District Court for the Northern District of California (the “Court”) against CH2M Hill, Inc. (“CH2M”) and four subcontractors of CH2M, including the Company (“Defendants”). The complaint alleges various claims, including a claim for negligence, negligent misrepresentation, equitable indemnification and related business claims against all defendants related to alleged damages suffered by Tetra Tech in respect of certain draft reports prepared by defendants at the request of the U.S. Navy as part of an investigation and review of certain whistleblower complaints about Tetra Tech’s environmental restoration at the Hunter’s Point Naval Shipyard in San Francisco.

CH2M was hired by the Navy in 2016 to review Tetra Tech’s work. CH2M subcontracted with environmental consulting and cleanup firms Battelle Memorial Institute, Cabrera Services, Inc., SC&A, Inc. and the Company to assist with the review, according to the complaint.

Our insurance carrier is providing a defense on our behalf in connection with this lawsuit, subject to a ~~$100,000~~$100,000 self-insured retention and the terms and limitations contained in the insurance policy.

On January 7, 2021, Defendants’ motion to dismiss the complaint in its entirety was granted without prejudice, with leave to amend. Tetra Tech subsequently filed a First Amended Complaint (“FAC”) and Defendants filed a motion to dismissThe majority of Tetra Tech’s FAC (the “Motion”). Tetra Tech filed an opposition to Defendant’s motion to dismiss Tetra Tech’s FAC. Defendants subsequently filed a joint reply to Tetra Tech’s motion in opposition. On January 27, 2022, the Motion was granted in part and denied in partclaims have been dismissed by the Court. ~~Tetra Tech’s~~Remaining claims for: (1) Negligence; (2) Equitable Indemnification/Contribution; and (3) Unfair Business Practices were dismissed. Tetra Tech was given leave to re-assert the Unfair Business Practices claim but chose not to do so, which means that claim is now also dismissed. Tetra Tech’s claims that survived the Motion are:include: (1) Intentional Interference with Contractual Relations; and (2) Inducing a Breach of Contract. The Company continues to believe it does not have any liability to Tetra Tech.

16
Perma-Fix Canada, Inc. (“PF Canada”)

During the fourth quarter of 2021, PF Canada received a Notice of Termination (“NOT”) from Canadian Nuclear Laboratories, LTD. (“CNL”) on a Task Order Agreement (“TOA”) that PF Canada entered into with CNL in May 2019 for remediation work within Ontario, Canada (“Agreement”). The NOT was received after work under the TOA was substantially completed and work under the TOA has since been completed. CNL may terminate the TOA at any time for convenience. As of ~~March 31,~~September 30, 2022, PF Canada has approximately $~~2,722,000~~2,385,000 in unpaid receivables ~~and unbilled costs~~ due from CNL as a result of work performed under the TOA. Additionally, CNL has approximately $~~1,150,000~~1,044,000 in contractual holdback under the TOA that is payable to PF Canada. CNL also established a bond securing approximately $1,900,000 (CAD) to cover certain issue raised in connection with the TOA. Under the TOA, CNL may be entitled to set off certain costs and expenses incurred by CNL in connection with the termination of the TOA, including the bond as discussed above, against amounts owed to PF Canada for work performed by PF Canada or its subcontractors. PF Canada continues to be in discussions with CNL to finalize the amounts due to PF Canada under the TOA and continues to ~~believes~~believe these amounts are due and payable.
19

Insurance

The Company has a 25-year finite risk insurance policy entered into in June 2003 (“2003 Closure Policy”) with AIG Specialty Insurance Company (“AIG”), which provides financial assurance to the applicable states for our permitted facilities in the event of unforeseen closure. The 2003 Closure Policy, as amended, provides for a maximum allowable coverage of $28,177,000 which includes available capacity to allow for annual inflation and other performance and surety bond requirements. Total coverage under the 2003 Closure Policy, as amended, was $~~21,047,000~~21,175,000 at ~~March 31,~~September 30, 2022. At ~~March 31,~~September 30, 2022 and December 31, 2021, finite risk sinking funds contributed by the Company related to the 2003 Closure Policy which is included in other long term assets on the accompanying Consolidated Balance Sheets totaled $~~11,482,000~~11,540,000 and $11,471,000, respectively, which included interest earned of $~~2,011,000~~2,069,000 and $2,000,000 on the finite risk sinking funds as of ~~March 31,~~September 30, 2022 and December 31, 2021, respectively. Interest income for the three and nine months ended ~~March 31,~~September 30, 2022 was approximately $29,000and $69,000, respectively. Interest income for the three and nine months ended September 30, 2021 was approximately $~~11,000~~2,000 and $~~18,000~~23,000, respectively. If we so elect, AIG is obligated to pay usthe Company an amount equal to 100% of the finite risk sinking fund account balance in return for complete release of liability from both usthe Company and any applicable regulatory agency using this policy as an instrument to comply with financial assurance requirements.
Letter of Credits and Bonding Requirements

From time to time, the Company is required to post standby letters of credit and various bonds to support contractual obligations to customers and other obligations, including facility closures. At ~~March 31,~~September 30, 2022, the total amount of standby letters of credit outstanding was approximately $~~3,020,000~~3,016,000 and the total amount of bonds outstanding was approximately $~~51,295,000~~59,322,000.

~~10.~~ ~~Discontinued Operations~~
10. Discontinued Operations

The Company’s discontinued operations consist of all our subsidiaries included in our ~~previous~~ Industrial Segment which encompasses subsidiaries divested in 2011 and prior and three previously closed locations.

The Company’s discontinued operations had net losses of $~~94,000~~160,000 ~~(net of tax benefit of $63,000~~) and $~~115,000~~43,000 ~~(net of taxes of $~~0) for the three months ended ~~March 31,~~September 30, 2022 and ~~2021.~~2021, respectively (net of tax benefits of $46,000 and $98,000 for the three month ended September 30, 2022 and 2021, respectively) and net losses of $442,000 and $285,000 for the nine months ended September 30, 2022 and 2021, respectively, (net of tax benefits of $127,000 and $98,000 for the nine month ended September 30, 2022 and 2021, respectively). The losses (excluding the tax benefits) were primarily due to costs incurred in the administration and continued ~~monitoring~~monitoring/evaluation of our discontinued operations. The Company’s discontinued operations had no revenues for ~~each~~any of the periods noted above.

1720
The following table presents the major class of assets of discontinued operations as of ~~March 31,~~September 30, 2022 and December 31, 2021. No assets and liabilities were held for sale at each of the periods noted.
Schedule of Disposal Groups, Including Discontinued Operation Balance Sheet
March 31, December 31, September 30, December 31,
(Amounts in Thousands) 2022 2021 2022 2021
Current assets
Other assets $ 27 $ 15 $ 17 $ 15
Total current assets 27 15 17 15
Long-term assets
Property, plant and equipment, net ⁽¹⁾ 81 81 81 81
Total long-term assets 81 81 81 81
Total assets $ 108 $ 96 $ 98 $ 96
Current liabilities
Accounts payable $ 34 $ 3 $ 23 $ 3
Accrued expenses and other liabilities 147 154 153 154
Environmental liabilities 621 349 751 349
Total current liabilities 802 506 927 506
Long-term liabilities
Closure liabilities 153 150 157 150
Environmental liabilities 255 527 110 527
Total long-term liabilities 408 677 267 677
Total liabilities $ 1,210 $ 1,183 $ 1,194 $ 1,183

⁽¹⁾ net of accumulated depreciation of $10,000 for each period presented.

~~11.~~ ~~Operating Segments~~
11. Operating Segments
In accordance with ASC 280, “Segment Reporting”, the Company defines an operating segment as a business activity: (1) from which we may earn revenue and incur expenses; (2) whose operating results are regularly reviewed by the chief operating decision maker (“CODM”) to make decisions about resources to be allocated to the segment and assess its performance; and (3) for which discrete financial information is available.

Our reporting segments are defined as below:

TREATMENT SEGMENT, which includes:

- nuclear, low-level radioactive, mixed waste (containing both hazardous and low-level radioactive constituents), hazardous and non-hazardous waste treatment, processing and disposal services primarily through four uniquely licensed and permitted treatment and storage facilities; and
- R&D activities to identify, develop and implement innovative waste processing techniques for problematic waste streams.

SERVICES SEGMENT, which includes:

- Technical services, which include:

○ professional radiological measurement and site survey of large government and commercial installations using advanced methods, technology and engineering;
○ integrated Occupational Safety and Health services including industrial hygiene (“IH”) assessments; hazardous materials surveys, e.g., exposure monitoring; lead and asbestos management/abatement oversight; indoor air quality evaluations; health risk and exposure assessments; health & safety plan/program development, compliance auditing and training services; and Occupational Safety and Health Administration (“OSHA”) citation assistance;
○ global technical services providing consulting, engineering, project management, waste management, environmental, and decontamination and decommissioning field, technical, and management personnel and services to commercial and government customers; and
○ on-site waste management services to commercial and governmental customers.

1821

- Nuclear services, which include:

○ technology-based services including engineering, decontamination and decommissioning (“D&D”), specialty services and construction, logistics, transportation, processing and disposal;
○ remediation of nuclear licensed and federal facilities and the remediation cleanup of nuclear legacy sites. Such services capability includes: project investigation; radiological engineering; partial and total plant D&D; facility decontamination, dismantling, demolition, and planning; site restoration; logistics; transportation; and emergency response; and

- A company owned equipment calibration and maintenance laboratory that services, maintains, calibrates, and sources (i.e., rental) health physics, IH and customized nuclear, environmental, and occupational safety and health (“NEOSH”) instrumentation.

The Company’s segment also included the Medical Segment in 2021. As previously discussed, the Company made the strategic decision to cease all R&D activities under the Medical Segment and sold 100% of its interest in PFM Poland (which comprised the Medical Segment) in December 2021. The Company’s Medical Segment had not generated any revenue and was involved in the Company’s medical isotope production technology.

Our reporting segments exclude our corporate headquarters and our discontinued operations (see “Note 10 – Discontinued Operations”) which do not generate revenues.

The table below presents certain financial information of our operating segments for the three and nine months ended ~~March 31,~~September 30, 2022 and 2021 (in thousands):.

Segment Reporting for the Quarter Ended ~~March 31,~~September 30, 2022
Schedule of Segment Reporting Information
Treatment Services Segments Total Corporate ⁽¹⁾ Consolidated Total
Revenue from external customers $ 8,877 $ 9,595 $ 18,472 $ — $ 18,472
Intercompany revenues 28 16 44 — —
Gross profit 1,967 1,103 3,070 — 3,070
Research and development 55 — 55 14 69
Interest income — — — 29 29
Interest expense (20 ) (2 ) (22 ) (25 ) (47 )
Interest expense-financing fees — — — (16 ) (16 )
Depreciation and amortization 387 87 474 23 497
Segment income (loss) before income taxes 1,792 725 2,517 (1,514 ) 1,003 ⁽²⁾
Income tax expense 164 15 179 — 179
Segment income (loss) 1,628 710 2,338 (1,514 ) 824
Expenditures for segment assets 149 39 188 1 189 ⁽³⁾
Treatment Services Segments Total Corporate⁽¹⁾ Consolidated Total
Revenue from external customers $ 7,479 $ 8,436 $ 15,915 $ — $ 15,915
Intercompany revenues 111 183 294 — —
Gross profit 638 998 1,636 — 1,636
Research and development 65 14 79 17 96
Interest income — — — 11 11
Interest expense (14 ) (1 ) (15 ) (20 ) (35 )
Interest expense-financing fees — — — (13 ) (13 )
Depreciation and amortization 371 71 442 14 456
Segment (loss) income before income taxes (481 ) 285 (196 ) (1,726 ) (1,922 )
Income tax benefit (559 ) (114 ) (673 ) — (673 )
Segment income (loss) 78 399 477 (1,726 ) (1,249 )
Expenditures for segment assets 296 49 345 — 345 ⁽²⁾
Segment Reporting for the Nine Months Ended September 30, 2022
Treatment Services Segments Total Corporate ⁽¹⁾ Consolidated Total
Revenue from external customers $ 24,749 $ 29,093 $ 53,842 $ — $ 53,842
Intercompany revenues 28 43 71 — —
Gross profit 4,168 3,422 7,590 — 7,590
Research and development 179 23 202 43 245
Interest income — — — 69 69
Interest expense (53 ) — (53 ) (70 ) (123 )
Interest expense-financing fees — — — (44 ) (44 )
Depreciation and amortization 1,139 244 1,383 50 1,433
Segment income (loss) before income taxes 1,675 1,524 3,199 (5,028 ) (1,829 )⁽²⁾
Income tax benefit (91 ) (56 ) (147 ) — (147 )
Segment income (loss) 1,766 1,580 3,346 (5,028 ) (1,682 )
Expenditures for segment assets 819 127 946 1 947 ⁽³⁾
22

Segment Reporting for the Quarter Ended ~~March 31,~~September 30, 2021

Treatment Services Medical Segments Total Corporate⁽¹⁾ Consolidated Total Treatment Services Medical Segments Total Corporate ⁽¹⁾ Consolidated Total
Revenue from external customers $ 7,495 $ 15,638 $ — $ 23,133 $ — $ 23,133 $ 8,893 $ 6,904 — $ 15,797 $ — $ 15,797
Intercompany revenues 660 7 — 667 — — 220 5 — 225 — —
Gross profit 925 1,431 — 2,356 — 2,356
Gross profit (negative gross profit) 2,487 (263 ) — 2,224 — 2,224
Research and development 47 13 76 136 14 150 52 18 162 232 11 243
Interest income — — — — 18 18 — — — — 2 2
Interest expense (19 ) (8 ) — (27 ) (40 ) (67 ) (51 ) (1 ) — (52 ) (25 ) (77 )
Interest expense-financing fees — — — — (8 ) (8 ) — — — — (11 ) (11 )
Depreciation and amortization 310 85 — 395 5 400 319 85 — 404 5 409
Segment (loss) income before income taxes (119 ) 555 (76 ) 360 (1,415 ) (1,055 )
Income tax benefit (17 ) — — (17 ) — (17 )
Segment (loss) income (102 ) 555 (76 ) 377 (1,415 ) (1,038 )
Segment income (loss) before income taxes 1,317 (984 ) (162 ) 171 (1,626 ) (1,455 )
Income tax expense (benefit) 1 — — 1 (2,837 ) (2,836 )⁽⁴⁾
Segment income (loss) 1,316 (984 ) (162 ) 170 1,211 1,381
Expenditures for segment assets 357 4 — 361 — 361 ⁽²⁾ 482 — — 482 — 482 ⁽⁶⁾
Segment Reporting for the Nine Months Ended September 30, 2021
Treatment Services Medical Segments Total Corporate ⁽¹⁾ Consolidated Total
Revenue from external customers $ 24,094 $ 30,981 — $ 55,075 $ — $ 55,075
Intercompany revenues 1,199 44 — 1,243 — —
Gross profit 4,845 701 — 5,546 — 5,546
Research and development 142 50 311 503 35 538
Interest income — — — — 23 23
Interest expense (88 ) (9 ) — (97 ) (112 ) (209 )
Interest expense-financing fees — — — — (28 ) (28 )
Depreciation and amortization 939 255 — 1,194 14 1,208
Segment income (loss) before income taxes 1,669 (1,721 ) (311 ) (363 ) 987 ⁽⁵⁾ 624
Income tax (benefit) expense (13 ) 10 — (3 ) (2,837 ) (2,840 )⁽⁴⁾
Segment income (loss) 1,682 (1,731 ) (311 ) (360 ) 3,824 3,464
Expenditures for segment assets 1,109 14 — 1,123 9 1,132 ⁽⁶⁾
⁽¹⁾ Amounts reflect the activity for corporate headquarters not included in the segment information.
⁽²⁾ Includes approximately $1,975,000 recorded as other income under the Employee Retention Credit program under the CARES Act, as amended (see “Note 13 – Employee Retention Credit (“ERC”) below for a discussion of this expected refund amount).
⁽³⁾ Net of financed amount of $~~114,000~~0 and $~~29,000~~114,000 for the three and nine months ended ~~March 31,~~September 30, 2022, respectively.
⁽⁴⁾ Includes tax benefit recorded in amount of approximately $2,351,000 resulting from release of valuation allowance on the Company’s deferred tax assets.
⁽⁵⁾ Includes approximately $5,381,000 of “Gain on extinguishment of debt” recorded in connection with the Company’s Paycheck Protection Program (“PPP”) Loan which was forgiven by the U.S. Small Business Administration effective June 15, 2021.
⁽⁶⁾ Net of financed amount of $271,000and $348,000 for the three and nine months ended September 30, 2021, respectively.

12. Asset Retirement Obligations (“ARO”) and Accrued Closure Costs
Accrued closure costs represent our estimated environmental liability to clean up our fixed-based regulated facilities as required by our permits, in the event of closure. During the nine months ended September 30, 2022, the Company recorded a total of $465,000 in additional estimated closure liabilities (within long-term liabilities) and ARO in connection with the footprint expansion at one of our facilities and an update to a processing enclosure area at another facility. Additionally, the Company recorded approximately $662,000 in additional estimated closure liabilities (within current liabilities) and ARO for our EWOC (Oak Ridge Environmental Waste Operations Center) facility. The ARO is reported as a component of “Net property and equipment” in the Consolidated Balance Sheets at September 30, 2022.
1923

~~12.~~ ~~Income Taxes~~
13. Employee Retention Credit (“ERC”)

The Coronavirus Aid, Relief and Economic Securities Act (“CARES Act”), which was enacted on March 27, 2020, provides an Employee Retention Credit (“ERC”) for qualifying businesses keeping employees on their payroll during the COVID-19 pandemic. The ERC was subsequently amended by the Taxpayer Certainty and Disaster Tax Relief Act of 2020, the Consolidated Appropriation Act of 2021, and the American Rescue Plan Act of 2021, all of which amended and extended the ERC availability and guidelines under the CARES Act. Following these amendments, the Company ~~uses~~determined that it was eligible for the ERC, and as a result of the foregoing legislations, is eligible to claim a refundable tax credit against the Company’s share of certain payroll taxes equal to 70% of the qualified wages paid to employees between July 1, 2021 and September 30, 2021. Qualified wages are limited to $10,000 per employee per calendar quarter in 2021 for a maximum allowable ERC per employee of $7,000 per calendar quarter in 2021. For purposes of the amended ERC, an ~~estimated annual effective~~eligible employer is defined as having experienced a significant (20% or more) decline in gross receipts during one or more of the first three 2021 calendar quarters when compared to 2019.
During the third quarter of 2022, the Company determined it was eligible for the ERC and amended its third quarter 2021 employer payroll tax ~~rate, which is based on expected annual income, statutory tax rates and tax planning opportunities available~~filings claiming a refund from the U.S. Treasury in the ~~various jurisdictions in which~~amount of approximately $1,975,000. As there is no authoritative guidance under U.S. GAAP on accounting for government assistance to for-profit business entities, we account for the ~~Company operates,~~ERC by analogy to ~~determine its quarterly provision~~International Accounting Standard (“IAS”) 20, Accounting for Government Grants and Disclosure of Government Assistance. In accordance with IAS 20, management determined it has reasonable assurance for receipt of the ERC and recorded the expected refund as other income ~~taxes.~~(within “Other income (expense)”) on the Company’s Consolidated Statements of Operations and other receivables (within “Prepaid and other assets”) on the Company’s Consolidated Balance Sheets.
14. Income Taxes

The Company had income tax expense of $179,000 and income tax benefit of ~~approximately~~ $~~673,000~~2,836,000 for continuing operations for the three months ended ~~March 31,~~September 30, 2022 ~~as compared to~~and 2021, respectively, and income tax ~~benefit~~benefits of ~~approximately~~ $~~17,000~~147,000 and $2,840,000 for ~~continuing operations for~~ the ~~three~~nine months ended ~~March 31, 2021.~~September 30, 2022 and 2021, respectively. The Company’s effective tax ~~rate was~~rates were approximately ~~35.0~~17.8% and ~~1.6~~194.9% for the three months ended ~~March 31,~~September 30, 2022 and 2021, respectively, and 8.0% and (455.1%) for the ~~corresponding period of~~nine months ended September 30, 2022 and 2021, respectively. The Company’s effective tax ~~rate~~rates for the three and nine months ended ~~March 31,~~September 30, 2022 ~~was~~were impacted by non-deductible expenses and state taxes. The Company’s effective tax ~~rate~~rates for the three and nine months ended ~~March 31,~~September 30, 2021 ~~was~~were substantially impacted by ~~non-deductible expenses, state taxes, and by~~the release of the Company’s ~~full~~ valuation ~~on its net deferred tax assets which was subsequently released partially in~~allowance during the third quarter of 2021. For the three and nine months ended September 30, 2021, the primary reasons for the differences between the Company’s effective tax rate and statutory tax rate were due to the release of valuation allowance and the forgiveness of the Company’s PPP Loan which was included in the Company’s Consolidated Statement of Operations as “Gain on extinguishment of debt” but is exempt from income taxes.

~~13.~~ ~~Variable Interest Entities (“VIE”)~~
15. Variable Interest Entities (“VIE”)
The Company and Engineering/Remediation Resources Group, Inc. (“ERRG”) previously entered into an unpopulated joint venture agreement for project work bids within the Company’s Services Segment with the joint venture doing business as Perma-Fix ERRG, a general partnership. The Company has a51% partnership interest in the joint venture and ERRG has a 49% partnership interest in the joint venture.

The Company determines whether joint ventures in which it has invested meet the criteria of a VIE at the start of each new venture and when a reconsideration event has occurred. A VIE is a legal entity that satisfies any of the following characteristics: (a) the legal entity does not have sufficient equity investment at risk; (b) the equity investors at risk as a group, lack the characteristics of a controlling financial interest; or (c) the legal entity is structured with disproportionate voting rights.

The Company consolidates a VIE if it is determined to be the primary beneficiary of the VIE. The primary beneficiary has both the power to direct the activities of the VIE that most significantly impact the entity’s economic performance and the obligation to absorb losses or the right to receive benefits from the VIE that could potentially be significant to the VIE.

Based on the Company’s evaluation of Perma-Fix ERRG and related agreements with Perma-Fix ERRG, the Company determined that Perma-Fix ERRG continues to be a VIE in which ~~we are~~the Company is the primary beneficiary. At ~~March 31,~~September 30, 2022, Perma-Fix ERRG had total assets of $~~122,000~~91,000 and total liabilities of ~~approximately~~ $~~122,000~~91,000 which are all recorded as current.

~~14.~~ ~~Executive Compensation~~
16. Subsequent Events
The Company’s Compensation Committee and the Board determined that no performance payment would be made to each executive officer under his 2021 Management Incentive Plan (“MIP”). In lieu of any performance payment to each executive officer under his 2021 MIP and in an attempt to retain the executive officer, on January 20, 2022, the Compensation Committee and the Board determined that the base annual compensation for each executive officer for 2022 is increased by approximately ~~6.4%, effective January 1, 2022, to offset the cost-of-living increase.~~

On January 20, 2022, the Board and the Compensation Committee also approved individual MIP for the calendar year 2022 for each of our executive officers. Each MIP is effective January 1, 2022 and applicable for year 2022. Each MIP provides guidelines for the calculation of annual cash incentive-based compensation, subject to Compensation Committee oversight and modification. The performance compensation under each of the MIPs is based upon meeting certain of the Company’s separate target objectives during 2022. Assuming each target objective is achieved under the same performance threshold range under each MIP, the total potential target performance compensation payable ranges from 25~~% to~~ ~~150% of the 2022 base salary for the CEO ($93,717~~ ~~to $562,304~~), 25~~% to~~ ~~100% of the 2022 base salary for the CFO ($76,193~~ ~~to $304,772~~), 25~~% to~~ ~~100% of the 2022 base salary for the EVP of Strategic Initiatives ($63,495~~ ~~to $253,980~~), 25~~% to~~ ~~100% of the 2022 base salary for the EVP of Nuclear and Technical Services ($76,193~~ ~~to $304,772) and~~ 25~~% to~~ ~~100% ($65,308~~ ~~to $261,233) of the 2022 base salary for the EVP of Waste Treatment Operations.~~
~~15.~~ ~~Subsequent Events~~
Management evaluated events occurring subsequent to ~~March 31,~~September 30, 2022 through ~~May 5,~~November 3, 2022, the date these consolidated financial statements were available for issuance, and determined that no material recognizable subsequent events occurred.
2024

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
~~Item 2.~~ ~~Management’s Discussion and Analysis of Financial Condition and Results of Operations~~

Forward-looking Statements

Certain statements contained within this report may be deemed “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (collectively, the “Private Securities Litigation Reform Act of 1995”). All statements in this report other than a statement of historical fact are forward-looking statements that are subject to known and unknown risks, uncertainties and other factors, which could cause actual results and performance of the Company to differ materially from such statements. The words “believe,” “expect,” “anticipate,” “intend,” “will,” and similar expressions identify forward-looking statements. Forward-looking statements contained herein relate to, among other things,

● demand for our services;
● reductions and improvement in the level of government funding in future years;
● reducing operating costs and non-essential expenditures;
● ability to meet loan agreement quarterly financial covenant requirements;
● cash flow requirements;
● Canadian receivable;
● sufficient liquidity to continue business;
● future results of operations and liquidity;
● effect of economic disruptions on our business;
● government funding for our services;
● may not have liquidity to repay debt if our lender accelerates payment of our borrowings;
● ~~deployment of unit;~~
● manner in which the applicable government will be required to spend funding to remediate various sites;
● funding operations;
● continued increases in pricing and/or further tightening supply chain;
● fund capital expenditures from cash from operations and/or financing;
● impact from COVID-19 and ~~impact from other delays;~~economic conditions;
● continue improvement in waste ~~shipments;~~receipts and project work;
● submitted bid;
● fund remediation expenditures for sites from funds generated internally;
● ownership percentage interest upon finalization of partnership agreement;
● investment requirement upon finalization of joint venture;
25
● positive trends;
● collection of accounts receivables;
● compliance with environmental regulations;
● potential effect of being a PRP;
● potential sites for violations of environmental laws and remediation of our facilities;
21● ERC refund;
● remediation of material weakness;
● future price increases; and
● continuation of contracts with federal government.

While the Company believes the expectations reflected in such forward-looking statements are reasonable, it can give no assurance such expectations will prove to be correct. There are a variety of factors, which could cause future outcomes to differ materially from those described in this report, including, but not limited to:

● general economic conditions;
● contract bids, including international markets;
● material reduction in revenues;
● inability to meet PNC covenant requirements;
● inability to collect in a timely manner a material amount of receivables;
● increased competitive pressures;
● inability to maintain and obtain required permits and approvals to conduct operations;
● public not accepting our new technology;
● inability to develop new and existing technologies in the conduct of operations;
● inability to maintain and obtain closure and operating insurance requirements;
● inability to retain or renew certain required permits;
● discovery of additional contamination or expanded contamination at any of the sites or facilities leased or owned by us or our subsidiaries which would result in a material increase in remediation expenditures;
● delays at our third-party disposal site can extend collection of our receivables greater than twelve months;
● refusal of third-party disposal sites to accept our waste;
● changes in federal, state and local laws and regulations, especially environmental laws and regulations, or in interpretation of such;
● requirements to obtain permits for TSD activities or licensing requirements to handle low level radioactive materials are limited or lessened;
● potential increases in equipment, maintenance, operating or labor costs;
● management retention and development;
● financial valuation of intangible assets is substantially more/less than expected;
● the requirement to use internally generated funds for purposes not presently anticipated;
● inability to continue to be profitable on an annualized basis;
● inability of the Company to maintain the listing of its Common Stock on the NASDAQ;
● terminations of contracts with government agencies or subcontracts involving government agencies or reduction in amount of waste delivered to the Company under the contracts or subcontracts;
● renegotiation of contracts involving government agencies;
● federal government’s inability or failure to provide necessary funding to remediate contaminated federal sites;
● disposal expense accrual could prove to be inadequate in the event the waste requires re-treatment;
● inability to raise capital on commercially reasonable terms;
● inability to increase profitable revenue;
● impact of the ~~COVID-19;~~COVID-19 and economic uncertainties;
● ~~delays in waste shipments and delay in activities under new contracts;~~26
● new governmental regulations;
● lender refuses to waive non-compliance or revise our covenant so that we are in compliance;
● continued supply chain interruptions;
● continued inflationary pressures;
● ~~other unanticipated factors;~~recession;
● challenge by regulatory authorities of our claim to the ERTC; and
●
risk factors and other factors set forth in “Special Note Regarding Forward-Looking Statements” contained in the Company’s 2021 Form 10-K and the “Forward-Looking Statements” contained in the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” (“MD&A”) of the first and second quarters 2022 Form 10-Qs and this ~~first~~third quarter 2022 Form 10-Q.

22
~~COVID-19 Impact and Impact due to Other Delays~~Overview

~~Our first quarter financial results continued~~Revenue increased by $2,675,000 or 16.9% to ~~be impacted by COVID-19. As previously disclosed, within our~~$18,472,000 for the three months ended September 30, 2022 from $15,797,000 for the corresponding period of 2021. Services Segment werevenue increased to $9,595,000 from $6,904,000 or approximately 39.0%. The increase was primarily due to achievement of full operational status on certain projects which had been delayed due to COVID-19 impact and/or administrative delays experienced ~~delays~~by certain customers since the award of the projects to us late in ~~procurement actions and contract awards during the first half of 2021 resulting from the impact of COVID-19. Since the end of~~ the second quarter of 2021, we were awarded a number of new contracts. However, due to continued COVID-19 impact and/or customer administrative delay experienced by certain customers, work under certain of our new awards was temporarily curtailed/delayed which continued for most of2021. As previously disclosed, starting in the ~~first~~second quarter of 2022, work under these projects had resumed/increased as the pandemic impacts began to subside and ~~negatively impacted revenue. We have, however, begun~~has since reached full operational status. Treatment Segment revenue decreased slightly by $16,000 or 0.2% for the third quarter of 2022 as compared to ~~see improvement in activities~~the corresponding period of 2021. Treatment Segment revenue for the three months ended September 30, 2021 included approximately $1,286,000 recognized from a significant request for equitable adjustment (“REA”) under a government waste generator contract resulting from certain pricing provisions of ~~these new projects~~the contract. Excluding this REA, Treatment Segment revenue increase approximately $1,270,000 or 16.7% in the third quarter of 2022 primarily due to higher waste volume which was offset by lower averaged price waste due to revenue mix. As previously disclosed, starting in the latter part of the ~~first~~second quarter of 2022, our Treatment Segment began to see improvements in waste receipt from certain customers who had previously delayed waste shipments due, in part, from the impact of COVID-19 which is reflected in our Treatment Segment waste backlog of $7,088,000 at September 30, 2022, an increase of approximately $967,000 or 15.8% from the balance of $6,121,000 at March 31, 2022. Our Treatment Segment revenue ~~continues to be~~was negatively impacted by ~~continued~~delays in waste ~~shipment delays~~shipments from certain customers ~~since the latter part of the first quarter of 2020, the start of the pandemic. We expect~~at our Florida facility due to see a gradual improvement in waste receipts from these customers in the upcoming months as our customers start easing up on COVID-19 restrictions; however, such may not be the case based on our customers’ own responses to COVID-19, including, but not limited to delaying or limiting full return-to-work schedules. Additionally, as a result of supply chain challenges, we experienced a delay in the delivery of a new technology waste processing unit from our supplier which negatively impacted our revenue as associated revenue was not able to be generated. Delivery of this unit had been expected during the third quarter of 2021 but did not occur until the latter part of the first quarter of 2022. Deployment of this unit is expected to commence in the second quarter of 2022. Within our Treatment Segment, we are experiencing a large increase in proposal requests.Hurricane Ian. We continue to have bids currently submitted in both segments and are awaiting awards. At this time, we expect to see continued steady improvements in waste receipts and increase work from projects, subject to potential impact of COVID-19 and other impacts (See “COVID-19 and Other Impacts” below for a discussion of uncertainties that COVID-19 and other economic impacts may have on the Company’s future results of operations).

~~At this time, we believe we have sufficient liquidity on hand~~Overall gross profit increased by $846,000 or 38.0%. Excluding the REA recorded in the third quarter of 2021 as discussed above, gross profit increased in both segments where Treatment Segment gross profit increased by approximately $766,000 primarily due to ~~continue business operations during~~higher revenue from higher waste volume which was partially offset by lower averaged priced waste from revenue mix and Services Segment gross profit increased by approximately $1,366,000 due to higher revenue from increased work. Selling, General, and Administrative (“SG&A”) expenses increased $581,000 or 17.4% for the ~~next twelve months. At March 31,~~three months ended September 30, 2022 as compared to the corresponding period of 2021.
During the third quarter of 2022, we ~~had borrowing availability~~recorded approximately $1,975,000 in other income and other receivables (within current assets in our Consolidated Balance Sheets), which represent an employee retention credit that we are eligible for under ~~our revolving credit facility of approximately $4,544,000 which was based on a percentage of eligible receivables and subject to certain reserves. As a~~the CARES Act (as amended) as result of ~~a recent amendment to our Loan Agreement, we are required to maintain a minimum of $3,000,000 in borrowing availability under our revolving credit until~~ the ~~minimum FCCR requirement for the quarter ended June 30, 2022 has been met and certified to our lender~~COVID-19 pandemic (see ~~“Financing Activities”~~“Employee Retention Credit (“ERC”)”) within this MD&A for a discussion of this ~~amendment). We continue to assess the need in reducing operating costs during~~refund that we are expecting resulting from this ~~volatile time, which may include curtailing certain capital expenditures and eliminating non-essential expenditures.~~
We are closely monitoring our customers’ payment performance. However, since a significant portion of our revenues is derived from government related contracts, we do not expect our accounts receivable collections to be materially impacted due to COVID-19.
As the situations surrounding COVID-19 continues to remain fluid, the full impact and extent of the pandemic on our financial results and liquidity cannot be estimated with any degree of certainty. We continue to closely monitor the impact of the COVID-19 pandemic on all aspects of our business, including supply chain challenges, our labor force and increasing costs from inflationary pressures (see “Known Trends and Uncertainties” – “Supply Chain” and “Inflation and Cost Increases” within this MD&A)tax credit).

2327

~~Overview~~
Revenue decreased by ~~$7,218,000~~$1,233,000 or ~~31.2%~~2.2% to ~~$15,915,000~~$53,842,000 for the ~~three months~~nine month ended ~~March 31,~~September 30, 2022 from ~~$23,133,000~~$55,075,000 for the corresponding period of 2021. The decrease was ~~primarily~~entirely within our Services Segment where revenue decreased to ~~$8,436,000~~$29,093,000 from ~~$15,638,000~~$30,981,000 or approximately ~~46.1%~~6.1%. As ~~discussed above,~~previously disclosed, work under certain of the new projects awarded to our Services Segment at the end of the second quarter of 2021 continued to be delayed/curtailed ~~for~~into most of the first quarter of 2022 due to COVID-19 impact and/or administrative delays experienced by certain customers. However, ~~we have begun to see improvement in activities from certain of~~as discussed above, work under these ~~new~~ projects had resumed/increased starting in the ~~latter part of the first~~second quarter of ~~2022.~~2022 and has since reached full operational status. The lower revenue in the first ~~quarter~~nine months of 2022 ~~resulting from delays/curtailments in work~~ was further exacerbated by the completion of a large project in the second quarter of 2021 which was not replaced with a similar size contract because of delays in contract awards and procurement from COVID-19 impact in the first half of 2021. Our Treatment Segment revenue ~~decreased slightly~~increased by ~~$16,000~~$655,000 or ~~0.2%~~2.7%. ~~Although we saw minimal overall change in revenue within Treatment Segment,~~As discussed above, our Treatment Segment revenue has not returned to pre-pandemic levels as certain customers continue to delay waste shipments due to impact of COVID-19. Gross profit decreased $720,000 or 30.6%. Selling, General, and Administrative (“SG&A”) expenses increased $217,000 or 6.8% for the three months ended ~~March 31,~~September 30, 2021 included approximately $1,286,000 recognized from a significant REA under a government waste generator contract resulting from certain pricing provisions of the contract. Excluding this REA, the increase in revenue of $1,941,000 or 8.5% for the nine months ended September 30, 2022 was primarily due to higher waste volume which was offset by lower averaged price waste due to revenue mix.
Overall gross profit for the nine months ended September 30, 2022 increased $2,044,000 or 36.9%. Excluding the REA recorded in the third quarter of 2021 as discussed above, gross profit increased in both segments where Treatment Segment gross profit increased by approximately $609,000 primarily due to higher revenue from higher waste volume which was partially offset by lower averaged priced waste from revenue mix and Services Segment gross profit increased by approximately $2,721,000 due to higher revenue from increased work. SG&A expenses increased $1,485,000 or 15.5% for the nine months ended September 30, 2022 as compared to the corresponding period of 2021.

COVID-19 and Other Impacts
Since the start of the COVID-19 pandemic, our financial results have been impacted by delays in waste shipments from certain customers, delays in procurement actions and contract awards, and delays/curtailment in work under projects. However, as disclosed above, we continue to see steady waste receipt improvements and work under projects resume/increase as our customers continue to ease up on COVID-19 restrictions. We continue to have submitted bids awaiting awards in both segments. At this time, we expect these positive trends to continue; however, such may not be the case based on the uncertainty of COVID-19 and how our customers respond to COVID-19. Even if the pandemic continues to subside, we may continue to experience adverse effect on our business and financial results because of economic impacts, including labor shortages, supply chain disruptions, as well as continued inflation or potential recession (see “Known Trends and Uncertainties” – “Supply Chain” and “Inflation and Cost Increases” within this MD&A).
We believe we have sufficient liquidity on hand to continue business operations during the next twelve months. At September 30, 2022, we had borrowing availability under our revolving credit facility of approximately $4,548,000 which was based on a percentage of eligible receivables and subject to certain reserves. As a result of an amendment to our Loan Agreement that we entered into with our lender in August 2022, we are required to maintain a minimum of $3,000,000 in borrowing availability under our revolving credit until the minimum FCCR requirement for the quarter ended December 31, 2022 has been met and certified to our lender (see “Financing Activities” within this MD&A for a discussion of this amendment). We continue to assess ways to improve our liquidity and the need in reducing operating costs during this volatile time. Reducing operating costs may include curtailing certain capital expenditures and eliminating non-essential expenditures.
We continue to closely monitor our customers’ payment performance. However, since a significant portion of our revenues is derived from government related contracts, we do not expect our accounts receivable collections to be materially impacted due to COVID-19.
As the situations surrounding COVID-19 and the countries’ economic conditions continue to remain fluid, the full impact and extent of the pandemic and the countries’ economic conditions on our financial results and liquidity cannot be estimated with any degree of certainty. We continue to closely monitor the impact of both the COVID-19 pandemic and the countries’ economic conditions on all aspects of our business.
28
Business Environment

Our Treatment and Services Segments’ business continues to be heavily dependent on services that we provide to governmental clients, primarily as subcontractors for others who are prime contractors to government entities or directly as the prime contractor. We believe demand for our services will continue to be subject to fluctuations due to a variety of factors beyond our control, including, without limitation, the economic conditions, the manner in which the applicable government will be required to spend funding to remediate various sites, and/or potential further impact from COVID-19. In addition, our governmental contracts and subcontracts relating to activities at governmental sites in the United States are generally subject to termination for convenience at any time at the government’s option, and our governmental contracts/task orders with the Canadian government authorities also allow the authorities to terminate the contract/task orders at any time for convenience. ~~Our work~~Work under all of our contracts/task order agreements with Canadian government authorities has substantially been completed. A significant account receivable due to PF Canada is subject to continuing negotiations. See “Known Trends and Uncertainties – Perma-Fix Canada, Inc. (“PF Canada”)” for additional discussion as to a terminated Canadian TOA. Significant reductions in the level of governmental funding or specifically mandated levels for different programs that are important to our business could have a material adverse impact on our business, financial position, results of operations and cash flows.

We are continually reviewing methods to raise additional capital to supplement our liquidity requirements, when needed, and reducing our operating costs. We continue to aggressively bid on various contracts, including potential contracts within the ~~international markets.~~international.
Based upon current regulations, for the Company’s 2022 Form 10-K, we will continue to be a SRC but no longer an accelerated filer.

Results of Operations

The reporting of financial results and pertinent discussions are tailored to our two reportable segments: The Treatment and Services. Our financial results for 2021 also included our Medical Segments. As previously disclosed, we made the strategic decision to cease all R&D activities under the Medical Segment and sold 100% of our interest in PFM Poland (which comprised the Medical Segment) in December 2021. Our Medical Segment had not generated any revenue and was involved in our medical isotope production technology. All costs previously incurred by the Medical Segment were included within R&D.

Summary – Three and Nine Months Ended September 30, 2022 and 2021
Three Months Ended Nine Months Ended
September 30, September 30,
Consolidated (amounts in thousands) 2022 % 2021 % 2022 % 2021 %
Net revenues $ 18,472 100.0 $ 15,797 100.0 $ 53,842 100.0 $ 55,075 100.0
Cost of goods sold 15,402 83.4 13,573 85.9 46,252 85.9 49,529 89.9
Gross profit 3,070 16.6 2,224 14.1 7,590 14.1 5,546 10.1
Selling, general and administrative 3,929 21.3 3,348 21.2 11,035 20.5 9,550 17.3
Research and development 69 .3 243 1.5 245 .5 538 1.0
Loss on disposal of property and equipment       —       — 1       — 1       — 1       —
Loss from operations (928 ) (5.0 ) (1,368 ) (8.6 ) (3,691 ) (6.9 ) (4,543 ) (8.2 )
Interest income 29 .2 2       — 69 .1 23       —
Interest expense (47 ) (.2 ) (77 ) (.5 ) (123 ) (.2 ) (209 ) (.4 )
Interest expense-financing fees (16 ) (.1 ) (11 ) (.1 ) (44 )       — (28 ) (.1 )
Other 1,965 10.6 (1 )       — 1,960 3.6       —       —
Gain on extinguishment of debt       —       —       —       —       —       — 5,381 9.8
Income (loss) from continuing operations before taxes 1,003 5.5 (1,455 ) (9.2 ) (1,829 ) (3.4 ) 624 1.1
Income tax expense (benefit) 179 1.0 (2,836 ) (17.9 ) (147 ) (.3 ) (2,840 ) (5.2 )
Income (loss) from continuing operations, net of taxes $ 824 4.5 $ 1,381 8.7 $ (1,682 ) (3.1 ) $ 3,464 6.3
2429

~~Summary – Three Months Ended March 31, 2022 and 2021~~
Three Months Ended
March 31,
Consolidated (amounts in thousands) 2022 % 2021 %
Revenues $ 15,915 100.0 $ 23,133 100.0
Cost of good sold 14,279 89.7 20,777 89.8
Gross profit 1,636 10.3 2,356 10.2
Selling, general and administrative 3,422 21.5 3,205 13.9
Research and development 96 .6 150 .6
Loss on disposal of property and equipment 1 — — —
Loss from operations $ (1,883 ) (11.8 ) $ (999 ) (4.3 )
Interest income 11 — 18 —
Interest expense (35 ) (.2 ) (67 ) (.2 )
Interest expense-financing fees (13 ) (.1 ) (8 ) —
Other (2 ) — 1 —
Loss from continuing operations before taxes (1,922 ) (12.1 ) (1,055 ) (4.5 )
Income tax benefit (673 ) (4.3 ) (17 ) —
Loss from continuing operations $ (1,249 ) (7.8 ) $ (1,038 ) (4.5 )
Revenues
Consolidated revenues ~~decreased $7,218,000~~increased $2,675,000 for the three months ended ~~March 31,~~September 30, 2022, compared to the three months ended ~~March 31,~~September 30, 2021, as follows:

(In thousands) 2022 % Revenue 2021 % Revenue Change % Change
Treatment
Government waste $ 5,437 34.2 $ 4,387 18.9 $ 1,050 23.9
Hazardous/non-hazardous ⁽¹⁾ 1,001 6.3 1,311 5.7 (310 ) (23.6 )
Other nuclear waste 1,041 6.5 1,797 7.8 (756 ) (42.1 )
Total 7,479 47.0 7,495 32.4 (16 ) (0.2 )

Services
Nuclear services 8,281 52.0 15,080 65.2 (6,799 ) (45.1 )
Technical services 155 1.0 558 2.4 (403 ) (72.2 )
Total 8,436 53.0 15,638 67.6 (7,202 ) (46.1 )

Total $ 15,915 100.0 $ 23,133 100.0 $ (7,218 ) (31.2 )
(In thousands) 2022 % Revenue 2021 % Revenue Change % Change
Treatment
Government waste $ 5,475 29.7 $ 6,164 39.0 $ (689 ) (11.2 )
Hazardous/non-hazardous ⁽¹⁾ 1,150 6.2 1,094 6.9 56 5.1
Other nuclear waste 2,252 12.2 1,635 10.4 617 37.7
Total 8,877 48.1 8,893 56.3 (16 ) (0.2 )

Services
Nuclear services 9,360 50.7 6,505 41.2 2,855 43.9
Technical services 235 1.2 399 2.5 (164 ) (41.1 )
Total 9,595 51.9 6,904 43.7 2,691 39.0

Total $ 18,472 100.0 $ 15,797 100.0 $ 2,675 16.9

⁽¹⁾Includes wastes generated by government clients of ~~$470,000~~$540,000 and ~~$745,000~~$597,000 for the three ~~months~~month ended ~~March 31,~~September 30, 2022 and the corresponding period of 2021, respectively.

Treatment Segment revenue decreased ~~slightly~~ by $16,000 or 0.2% for the three months ended ~~March 31,~~September 30, 2022 over the same period in 2021. ~~The decrease~~Treatment Segment revenue for the three months ended September 30, 2021 included a significant REA in ~~hazardous/non-hazardous~~the amount of approximately $1,286,000 recognized under a government waste generator contract resulting from certain pricing provisions of the contract. Excluding this REA, the overall increase in revenue of $1,270,000 or 16.7% was primarily due to ~~lower~~higher waste ~~volume. Revenue from other nuclear waste~~volume which was ~~lower primarily due to~~partly offset by lower averaged price ~~waste. Waste from government generators increased by approximately $1,050,000 or 23.9% primarily~~waste due ~~higher waste volume. Although we saw minimal overall change in~~to revenue ~~within Treatment Segment,~~mix. As previously disclosed, since the latter part of the second quarter of 2022, our Treatment Segment ~~revenue has not returned~~began to ~~pre-pandemic levels as~~see improvement in waste receipts from certain customers ~~continue to delay~~who had previously delayed waste shipments due, in part, to impact of COVID-19. This improvement has continued in the third quarter but was partly negatively impacted by some delays in waste shipment from certain customers at our Florida facility from Hurricane Ian. Services Segment revenue increased by approximately $2,691,000 or 39.0% primarily due to achievement of full operational status on certain projects which had previously been delayed/curtailed due to COVID-19 impact and/or administrative delays experienced by certain customers since the award of these projects to us late in the second quarter of 2021. Since the second quarter of 2022, work under these projects had resumed/increased and has since reached full operational status. Our Services Segment revenues are project based; as such, the scope, duration and completion of each project vary. As a result, our Services Segment revenues are subject to differences relating to timing and project value.
Consolidated revenues decreased $1,233,000 for the nine months ended September 30, 2022, as compared to the nine months ended September 30, 2021, as follows:
(In thousands) 2022 % Revenue 2021 % Revenue Change % Change
Treatment
Government waste $ 16,666 31.0 $ 15,653 28.4 $ 1,013 6.5
Hazardous/non-hazardous ⁽¹⁾ 3,515 6.5 3,722 6.8 (207 ) (5.6 )
Other nuclear waste 4,568 8.5 4,719 8.5 (151 ) (3.2 )
Total 24,749 46.0 24,094 43.7 655 2.7

Services
Nuclear services 28,320 52.6 29,832 54.2 (1,512 ) (5.1 )
Technical services 773 1.4 1,149 2.1 (376 ) (32.7 )
Total 29,093 54.0 30,981 56.3 (1,888 ) (6.1 )

Total $ 53,842 100.0 $ 55,075 100.0 $ (1,233 ) (2.2 )
⁽¹⁾Includes wastes generated by government clients of $1,652,000 and $1,886,000 for the nine month ended September 30, 2022 and the corresponding period of 2021, respectively.
30
Treatment Segment revenue increased by $655,000 or 2.7% for the nine months ended September 30, 2022 over the same period in 2021. Excluding the significant REA of $1,286,000 recorded in the third quarter of 2021 as discussed above, the overall increase in revenue of $1,941,000 or 8.5% was primarily due to higher waste volume as we continue to see steady improvements in waste receipts as our customers continue to ease up on COVID-19 restrictions. As disclosed above, this steady improvement in waste receipts was negatively impacted by some delays in waste shipment from certain customers at our Florida facility from Hurricane Ian. The higher revenue from higher waste volume was offset by lower averaged price waste from revenue mix. Services Segment revenue decreased by approximately ~~$7,202,000~~$1,888,000 or ~~46.1%~~6.1%. ~~Work~~As previously disclosed, work under certain of the new projects awarded to our Services Segment at the end of the second quarter of 2021 continued to be delayed/curtailed ~~for~~into most of the first quarter of 2022 due to COVID-19 impact and/or administrative delays experienced by certain customers. However, ~~we have begun to see improvement in activities from certain of these new projects starting in~~as previously disclosed, since the ~~latter part of the first~~second quarter of ~~2022.~~2022, work under these projects had resumed/increased and has since reached full operational status. The lower revenue in the first ~~quarter~~nine months of 2022 ~~resulting from delays/curtailments in work~~ was further exacerbated by the completion of a large project in the second quarter of 2021 which was not replaced with a similar size contract ~~from~~because of delays in contract awards and procurement from COVID-19 impact in the first half of 2021. Our Services Segment revenues are project based; as such, the scope, duration and completion of each project vary. As a result, our Services Segment revenues are subject to differences relating to timing and project value.
25
Cost of Goods Sold

Cost of goods sold ~~decreased $6,498,000~~increased $1,829,000 for the quarter ended ~~March 31,~~September 30, 2022, as compared to the quarter ended ~~March 31,~~September 30, 2021, as follows:

% %
(In thousands) 2022 Revenue 2021 Revenue Change
Treatment $ 6,841 91.5 $ 6,570 87.7 $ 271
Services 7,438 88.2 14,207 90.8 (6,769 )
Total $ 14,279 89.7 $ 20,777 89.8 $ (6,498 )
% %
(In thousands) 2022 Revenue 2021 Revenue Change
Treatment $ 6,910 77.8 $ 6,406 72.0 $ 504
Services 8,492 88.5 7,167 103.8 1,325
Total $ 15,402 83.4 $ 13,573 85.9 $ 1,829

Cost of goods sold for the Treatment Segment increased by approximately ~~$271,000~~$504,000 or ~~4.1%~~7.9%. ~~The~~Treatment Segment’s variable costs increased ~~costs was~~by approximately $365,000 primarily ~~due to higher~~in transportation and material and supplies costs. Treatment Segment’s overall fixed costs ofwere higher by approximately ~~$277,000~~$139,000 resulting from the following: general expenses were higher by ~~$144,000~~$96,000 mostly due to higher utility costs; depreciation expenses were higher by approximately $65,000 due to depreciation for asset retirement obligations in connection with our EWOC facility; maintenance costs were higher by approximately $36,000; regulatory expenses were lower by approximately $16,000; travel expenses were lower by approximately $20,000 and payroll related and travel costs were lower by approximately $22,000. Services Segment cost of goods sold increased $1,325,000 or 18.5% primarily due to higher ~~utility costs;~~revenue. The increase in cost of goods sold was primarily due to higher salaries/payroll related costs, travel, outside services and general costs totaling approximately $1,451,000. The overall higher costs were offset by lower disposal and materials and supplies costs. Included within cost of goods sold is depreciation and amortization expense of $471,000 and $403,000 for the three months ended September 30, 2022, and 2021, respectively.
31
Cost of goods sold decreased $3,277,000 for the nine months ended September 30, 2022, as compared to the nine months ended September 30, 2021, as follows:
% %
(In thousands) 2022 Revenue 2021 Revenue Change
Treatment $ 20,581 83.2 $ 19,249 79.9 $ 1,332
Services 25,671 88.2 30,280 97.7 (4,609 )
Total $ 46,252 85.9 $ 49,529 89.9 $ (3,277 )
Cost of goods sold for the Treatment Segment increased by approximately $1,332,000 or 6.9%. Treatment Segment’s variable costs increased by approximately $593,000 primarily due to higher material and supplies, transportation, and outside services costs. Treatment Segment’s overall fixed costs were higher by approximately $739,000 resulting from the following: salaries and payroll related expenses were higher by ~~approximately $49,000;~~$97,000 as in the prior year, more vacation hours were used by employees during the first nine months of 2021 which reduced the first nine months prior year payroll costs; general expenses were higher by $380,000 mostly due to higher utility costs; depreciation expenses were higher by approximately ~~$59,000~~$193,000 due to depreciation for asset retirement obligations in connection with our EWOC facility; regulatory expenses were higher by approximately ~~$15,000;~~$16,000; maintenance costs were higher by approximately $86,000; and travel expenses were ~~higher by $10,000 resulting from easing up of COVID-19 restrictions. Treatment Segment’s variable costs decreased slightly~~lower by approximately ~~$6,000 primarily due to lower overall costs in disposal, transportation, material and supplies which were mostly offset by higher outside services costs.~~$33,000. Services Segment cost of goods sold decreased ~~approximately $6,769,000~~$4,609,000 or ~~47.6%~~15.2% primarily due to lower revenue. The decrease in cost of goods sold was primarily due to lower salaries/payroll related, ~~travel,~~disposal and outside services ~~expenses~~costs totaling ~~$6,909,000. The overall lower costs were partially~~approximately $5,195,000 which was offset by higher material and supplies ~~costs.~~and general expenses. Included within cost of goods sold is depreciation and amortization expense of ~~$439,000~~$1,373,000 and ~~$394,000~~$1,191,000 for the ~~three~~nine months ended ~~March 31,~~September 30, 2022, and 2021, respectively.

Gross Profit

Gross profit for the quarter ended ~~March 31,~~September 30, 2022 ~~decreased $720,000~~increased $846,000 over the ~~corresponding~~same period of 2021, as follows:

% %
(In thousands) 2022 Revenue 2021 Revenue Change
Treatment $ 638 8.5 $ 925 12.3 $ (287 )
Services 998 11.8 1,431 9.2 (433 )
Total $ 1,636 10.3 $ 2,356 10.2 $ (720 )
% %
(In thousands) 2022 Revenue 2021 Revenue Change
Treatment $ 1,967 22.2 $ 2,487 28.0 $ (520 )
Services 1,103 11.5 (263 ) (3.8 ) 1,366
Total $ 3,070 16.6 $ 2,224 14.1 $ 846

Treatment Segment gross profit decreased by ~~$287,000~~$520,000 or ~~31.0%~~20.9%. Excluding the significant REA of approximately $1,286,000 recorded during the third quarter of 2021 as discussed above, Treatment Segment gross profit increased by approximately $766,000 or 63.8% and gross margin ~~decreased~~increased to ~~8.5%~~22.2% from ~~12.3%~~15.8% primarily due to ~~the impact of our fixed costs.~~increased waste volume which was partly offset by lower averaged price waste from revenue mix. Services Segment gross profit ~~decreased~~increased by ~~$433,000~~$1,366,000 or ~~30.3%~~519.4% and gross margin increased to 11.5% from ~~9.2%~~a negative 3.8% primarily due to ~~11.8%.~~higher revenue and higher margin projects. Our overall Services Segment gross margin is impacted by our current projects which are competitively bid on and will therefore, have varying margin structures.

Gross profit for the nine months ended September 30, 2022 increased $2,044,000 over the same period in 2021, as follows:
% %
(In thousands) 2022 Revenue 2021 Revenue Change
Treatment $ 4,168 16.8 $ 4,845 20.1 $ (677 )
Services 3,422 11.8 701 2.3 2,721
Total $ 7,590 14.1 $ 5,546 10.1 $ 2,044
Treatment Segment gross profit decreased by $677,000 or 14.0%. Excluding the significant REA of approximately $1,286,000 recorded in the third quarter of 2021 as discussed above, Treatment Segment gross profit increased $609,000 or 17.1% and gross margin increased to 16.8% from 15.6% primarily due to higher revenue from higher waste volume which was offset by lower averaged price waste from revenue mix and the impact of our fixed costs which continue to include much higher utility costs. Services Segment gross profit increased by $2,721,000 or 388.2% and gross margin increased from 2.3% to 11.8% primarily due to higher revenue and more higher margin projects. Our overall Services Segment gross margin is impacted by our current projects which are competitively bid on and will therefore, have varying margin structures.
32
SG&A

SG&A expenses increased ~~$217,000~~$581,000 for the three months ended ~~March 31,~~September 30, 2022, as compared to the corresponding period for 2021, as follows:

(In thousands) 2022 % Revenue 2021 % Revenue Change
Administrative $ 1,687 — $ 1,372 — $ 315
Treatment 1,040 13.9 978 13.0 62
Services 695 8.2 855 5.5 (160 )
Total $ 3,422 21.5 $ 3,205 13.9 $ 217
26
(In thousands) 2022
%
Revenue
2021
%
Revenue
Change
Administrative $ 1,826 — $ 1,580 — $ 246
Treatment 1,144 12.9 1,066 12.0 78
Services 959 10.0 702 10.2 257
Total $ 3,929 21.3 $ 3,348 21.2 $ 581

Administrative SG&A expenses were higher primarily due to the following: overall outside services expenses were higher by approximately ~~$174,000 resulting~~$157,000 from ~~more~~higher consulting/~~legal/~~outside ~~services matters;~~services/audit fees; travel expenses were higher by approximately $6,000; general expenses were higher by approximately $12,000 in various categories; and salaries and payroll related expenses were higher by approximately ~~$116,000~~$71,000 due to higher stock-based compensation expenses from options granted to certain employees in October 2021 and higher 401(k) plan matching expenses as our payroll expenses in the third quarter of 2021 included forfeitures of 401(k) plan matching funds contributed by us for former employees who failed to meet the 401(k) plan vesting requirements. Additionally, Administrative salaries and payroll related expenses were higher in the quarter as in 2021, resources were allocated in supporting Medical Segment’s R&D/administrative functions. Treatment Segment SG&A expenses were higher primarily due to the following: outside services expense were higher by $32,000 due to more consulting/business matters; general expenses were higher by approximately $54,000 which included higher tradeshow expenses and various other categories; salaries and payroll related expenses were higher by approximately $10,000; and travel expense were lower by approximately $18,000. The increase in Services Segment SG&A was primarily due to higher salaries/payroll related and consulting expenses totaling approximately $176,000 due to bid and proposals efforts; higher travel expenses by approximately $14,000 and higher general expenses by approximately $67,000 which included higher tradeshow expenses and various other categories. Included in SG&A expenses is depreciation and amortization expense of $26,000 and $6,000 for the three months ended September 30, 2022, and 2021, respectively.
SG&A expenses increased $1,485,000 for the nine months ended September 30, 2022, as compared to the corresponding period for 2021, as follows:
(In thousands) 2022
%
Revenue
2021
%
Revenue
Change
Administrative $ 5,278 — $ 4,243 — $ 1,035
Treatment 3,302 13.3 2,945 12.2 357
Services 2,455 8.4 2,362 7.6 93
Total $ 11,035 20.5 $ 9,550 17.3 $ 1,485
Administrative SG&A expenses were higher primarily due to the following: overall outside services expenses were higher by approximately $491,000 resulting from higher consulting/outside services/audit fees; travel expenses were higher by approximately $31,000; general expenses were higher by approximately $32,000 in various categories; and salaries and payroll related expenses were higher by approximately $481,000 primarily due to higher stock-based compensation expenses from options granted to certain employees in October 2021 and higher 401(k) plan matching expenses as our payroll expenses in the first nine months of 2021 included forfeitures of 401(k) plan matching funds contributed by us for former employees who failed to meet the 401(k) plan vesting requirements. Additionally, Administrative salaries and payroll related expenses were higher as in 2021, resources were allocated in supporting Medical Segment’s R&D/administrative functions; director fees were higher by approximately $18,000 resulting from one additional director who joined the Board in May 2021; travel expenses were higher by approximately $12,000; and general expenses were lower by approximately $5,000.functions. Treatment Segment SG&A expenses were higher primarily due to the following: salaries and payroll related expenses were higher ~~trade show~~by approximately $84,000 as in the prior year, more vacation hours were used by employees during the first nine months of 2021 which reduced the first nine months prior year payroll costs; outside services expense were higher by $76,000 due to more consulting/business matters (including our Environmental, Social and Governance initiatives); travel ~~costs resulting from easing up of COVID-19 restrictions.~~expense were higher by approximately $39,000; and general expenses were higher by $158,000 which included higher tradeshow expenses and various other categories. The ~~decrease~~increase in SG&A expenses within our Services Segment was primarily due to the following: travel expenses were higher by $32,000; general expenses were higher by approximately $95,000 which included higher tradeshow expenses and various other categories; and salaries/payroll related and consulting expenses were lower by approximately ~~$130,000~~$34,000 as in 2021, increased hours and consulting costs were spent on bid and proposal ~~efforts; bad debt expenses were lower by approximately $38,000; general expenses were slightly lower by $6,000 and travel expenses were higher by approximately $14,000.~~ efforts. Included in SG&A expenses is depreciation and amortization expense of ~~$17,000~~$60,000 and ~~$6,000~~$17,000 for the ~~three~~nine months ended ~~March 31,~~September 30, 2022 and 2021, respectively.

33
R&D

R&D expenses decreased ~~$54,000~~$174,000 and 293,000 for the three and nine months ended ~~March 31,~~September 30, 2022, respectively, as compared to the corresponding period ~~for 2021, as follows:~~of 2021.

(In thousands) 2022 2021 Change
Administrative $ 17 $ 14 $ 3
Treatment 65 47 18
Services 14 13 1
PF Medical — 76 (76 )
Total $ 96 $ 150 $ (54 )
Three Months Ended
September 30, Nine Months Ended
September 30,
(In thousands) 2022 2021 Change 2022 2021 Change
Administrative $ 14 $ 11 $ 3 $ 43 $ 35 $ 8
Treatment 55 52 3 179 142 37
Services — 18 (18 ) 23 50 (27 )
PF Medical — 162 (162 ) — 311 (311 )
Total $ 69 $ 243 $ (174 ) $ 245 $ 538 $ (293 )

R&D costs consist primarily of employee salaries and benefits, laboratory costs, third party fees, and other related costs associated with the development of new technologies and technological enhancement of new potential waste treatment processes. The decrease was primarily the result of the sale of PF Poland in December 2021 which comprised of our Medical Segment and which previously was involved in the R&D of our medical isotope technology.

Interest Income
Interest income increased by approximately $27,000 and $46,000 for the three and nine months ended September 30, 2022, respectively, as compared to the corresponding period of 2021 primarily due to higher interest earned from lower finite risk sinking fund.
Interest Expense

Interest expense decreased by approximately ~~$32,000 in~~$30,000 and $86,000 for the ~~first quarter of~~three and nine months ended September 30, 2022, respectively, as compared to the corresponding period of 2021 primarily due to lower interest expense from our declining term loan balance outstanding. Also, interest expense for the first ~~quarter~~six months of 2021 included interest accrued for our Paycheck Protection Program ~~(“PPP”)~~ Loan which was forgiven by the U.S. Small Business Administration effective June 15, 2021.

Income Taxes

We had income tax expense of $179,000 and income tax benefit of ~~approximately $673,000~~$2,836,000 for continuing operations for the three months ended ~~March 31,~~September 30, 2022 ~~as compared to~~and 2021, respectively, and income tax ~~benefit~~benefits of $147,000 and $2,840,000 for the nine months ended September 30, 2022 and 2021, respectively. Our effective tax rates were approximately ~~$17,000 for continuing operations~~17.8% and 194.9% for the three months ended ~~March 31, 2021.~~September 30, 2022 and 2021, respectively, and 8.0% and (455.1%) for the nine months ended September 30, 2022 and 2021, respectively. Our effective tax ~~rate was approximately 35.0% and 1.6%~~rates for the three and nine months ended ~~March 31,~~September 30, 2022 ~~and the corresponding period of 2021, respectively. Our tax rate for the three months ended March 31, 2022 was~~were impacted by non-deductible expenses and state taxes. Our effective tax ~~rate~~rates for the three and nine months ended ~~March 31,~~September 30, 2021 ~~was~~were substantially impacted by ~~non-deductible expenses, state taxes, and~~ the ~~full~~release of our valuation ~~on our net deferred tax assets which was subsequently released partially in~~allowance during the third quarter of 2021. For the three and nine months ended September 30, 2021, the primary reasons for the differences between our effective tax rate and statutory tax rate were due to the release of valuation allowance and the forgiveness of our PPP Loan which was included in our Consolidated Statement of Operations as “Gain on extinguishment of debt” but is exempt from income taxes.

2734

Liquidity and Capital Resources

Our cash flow requirements during the ~~three~~nine months ended ~~March 31,~~September 30, 2022 were primarily financed by our operations, cash on hand and credit facility availability. Subject to ~~the impact of~~ COVID-19 and other ~~delays~~impacts as discussed above, our cash flow requirements for the next twelve months will consist primarily of general working capital needs, scheduled principal payments on our debt obligations, remediation projects, and planned capital expenditures. We plan to fund these requirements from our operations, credit facility availability, ~~our capital expenditure line and~~ cash on ~~hand.~~hand and a refund that we expect to receive under the ERC program under the CARES Act, as amended (see a discussion of this expected refund below – “Employee Retention Credit (“ERC”)). We continue to explore all sources of increasing our capital ~~to supplement our~~and/or liquidity ~~requirements, when needed,~~ and to improve our revenue and working capital. We are continually reviewing operating costs and reviewing the possibility of further reducing operating costs and non-essential expenditures to bring them in line with revenue levels, when necessary. At this time, we believe that our cash flows from operations, our available liquidity from our credit facility, our ~~capital expenditure line and our~~ cash on hand and the expected refund from the ERC program should be sufficient to fund our operations for the next twelve months. However, due to the uncertainty of COVID-19 ~~and other delays~~ as disclosed in “COVID-19 ~~Impact~~ and ~~Impact due to~~ Other ~~Delays”~~Impacts” within this MD&A, there are no assurances such will be the case.

The following table reflects the cash flow activities during the first ~~three~~nine months of 2022:

(In thousands)
Cash provided by operating activities of continuing operations $ 148
Cash used in operating activities of discontinued operations (142 )
Cash used in investing activities of continuing operations (321 )
Cash used in financing activities of continuing operations (189 )
Decrease in cash and finite risk sinking fund (restricted cash) $ (504 )
(In thousands)
Cash used in operating activities of continuing operations $ (334 )
Cash used in operating activities of discontinued operations (559 )
Cash used in investing activities of continuing operations (922 )
Cash used in financing activities of continuing operations (694 )
Effect of exchange rate changes in cash (4 )
Decrease in cash and finite risk sinking fund (restricted cash) $ (2,513 )

At ~~March 31,~~September 30, 2022, we were in a positive cash position with no revolving credit balance. At ~~March 31,~~September 30, 2022, we had cash on hand of approximately ~~$3,925,000, which included account balances of our foreign subsidiaries totaling approximately $67,000.~~$1,858,000.

Operating Activities
Accounts receivable, net of allowances for doubtful accounts, totaled ~~$10,322,000~~$9,993,000 at ~~March 31,~~September 30, 2022, a decrease of ~~$1,050,000~~$1,379,000 from the December 31, 2021 balance of $11,372,000. The decrease was ~~primarily due~~attributed to timing of ~~accounts receivable collection~~invoicing and timing of ~~invoicing.~~our accounts receivable collection. Our contracts with our customers are subject to various payment terms and conditions; therefore, our accounts receivable are impacted by these terms and conditions and the related timing of accounts receivable collections. Additionally, our contracts with our customers may sometimes result in modifications which can cause delays in collections. Our accounts receivable at September 30, 2022 include invoices for work performed which previously was in our unbilled account for a certain Canadian project that remain outstanding and subject to negotiations (see unbilled receivables discussion below). See discussion under “Known Trends and Uncertainties – Perma-Fix Canada, Inc. (“PF Canada”) for a discussion as to certain account receivable.

Unbilled receivables totaled ~~$5,275,000~~$6,306,000 at ~~March 31,~~September 30, 2022, a decrease of ~~$3,720,000~~$2,689,000 from the December 31, 2021 balance of $8,995,000. The decrease in unbilled receivables was primarily within our Services Segment due to invoicing in connection with our Canadian projects.

Accounts payable, totaled ~~$10,329,000~~$10,37,000 at ~~March 31,~~September 30, 2022, a decrease of ~~$1,646,000~~$1,605,000 from the December 31, 2021 balance of $11,975,000. Our accounts payable are impacted by the timing of payments as we are continually managing payment terms with our vendors to maximize our cash position throughout all segments.

35
We had working capital of ~~$2,341,000~~$1,505,000 (which included working capital of our discontinued operations) at ~~March 31,~~September 30, 2022, as compared to working capital of $4,060,000 at December 31, 2021. Our working capital was negatively impacted primarily by our results of operations which were heavily impacted from COVID-19 and other delays, especially in the first quarter of 2022. Additionally, our working capital was negatively impacted by the reclass of approximately $400,000 in remediation reserve within our discontinued operations from long-term to current and the approximately $621,000 in additional current closure liabilities recorded for our EWOC facility. Our working capital was positively impacted by the employee retention credit in the amount of approximately $1,975,000 recorded as ~~discussed above.~~current receivables (within “Prepaid and other assets” in our Consolidated Balance Sheets. See a discussion of this credit below “Employee Retention Credit (“ERC”)”).
28

Investing Activities

For the ~~three~~nine months ended ~~March 31,~~September 30, 2022, our purchases of capital equipment totaled approximately ~~$459,000,~~$1,061,000, of which $114,000 was subject to financing, with the remaining funded from cash from operations and our credit facility. We have budgeted approximately $2,000,000 for 2022 capital expenditures primarily for our Treatment and Services Segments to maintain operations and regulatory compliance requirements and support revenue growth. Certain of these budgeted projects may either be delayed until later years or deferred altogether. We plan to fund our capital expenditures from cash from operations and/or financing. The initiation and timing of projects are also determined by financing alternatives or funds available for such capital projects.

During March 2022, we signed a joint venture term sheet addressing plans to partner with Springfields Fuels Limited (“SFL”), an affiliate of Westinghouse Electric Company LLC, to develop and manage a nuclear waste-materials treatment facility (the “Facility”) in the United Kingdom. The Facility is for the purpose of expanding the partners’ waste treatment capabilities for the European nuclear market. It is expected that upon finalization of a partnership agreement, SFL will have an ownership interest of fifty-five (55) percent and our interest will be forty-five (45) percent. The finalization, form and capitalization of this unpopulated partnership is subject to numerous conditions, including but not limited to, winning a certain contract, completion and execution of a definitive agreement and facility design, ~~and the~~ granting of required regulatory, lender or permitting ~~approvals.~~approvals and updated cost and profitability analysis based on current and forecast future economic conditions. Upon finalization of this venture, we will be required to make an investment in this venture. The amount of our investment, the period of which it is to be made and the method of funding are to be determined.

Financing Activities

We entered into a Second Amended and Restated Revolving Credit, Term Loan and Security Agreement, dated May 8, 2020, ~~(“Loan~~(the “Loan Agreement”), with PNC National Association (“PNC”), acting as agent and lender. The Loan Agreement ~~provides~~provided us with the following credit facility with a maturity date of March 15, 2024: (a) up to $18,000,000 revolving credit (“revolving credit”) and (b) a term loan (“term loan”) of approximately $1,742,000, requiring monthly installments of $35,547. The maximum that we can borrow under the revolving credit is based on a percentage of eligible receivables (as defined) at any one time reduced by outstanding standby letters of credit and borrowing reductions that our lender may impose from time to time. Our Loan Agreement, as amended (the “Amended Loan Agreement”), also provides a capital expenditure line of up to $1,000,000 with advances on the line, subject to certain limitations, permitted for up to twelve months starting May 4, 2021 (the “Borrowing Period”). Only interest is payable on advances during the Borrowing Period. At the end of the Borrowing Period, the total amount advanced under the line will amortize equally based on a five-year amortization schedule with principal payment due monthly plus interest. At the maturity date of the Amended Loan Agreement, ~~as amended,~~ any unpaid principal balance plus interest, if any, will become due. NoAt the end of the Borrowing Period, advance on the capital line ~~has been~~totaled approximately $524,000. We are required to make monthly principal installment payment of approximately $8,700 starting June 1, 2022 plus interest. At September 30, 2022, balance on the capital line was approximately $480,000. The advance made ~~as of March 31, 2022.~~on the capital line was used to purchase the underlying asset under a previous finance lease.
36

On March 29, 2022, we entered into an amendment to our Amended Loan Agreement with our lender which provided, among other things, the following:

● waived our failure to meet the minimum quarterly FCCR requirement for the fourth quarter of 2021;
● removes the quarterly FCCR testing requirement for the first quarter of 2022;
● reinstates the quarterly FCCR testing requirement starting for the second quarter of 2022 and revises the methodology to be used in calculating the FCCR for the quarters ending June 30, 2022, September 30, 2022, and December 31, 2022 (with no change to the minimum 1.15:1 ratio requirement for each quarter);
● requires maintenance of a minimum of $3,000,000 in borrowing availability under the revolving credit until the minimum FCCR requirement for the quarter ended June 30, 2022 has been met and certified to the lender; and
● revises the annual rate used to calculate the Facility Fee (as defined in the Loan Agreement) on the revolving credit, with addition of the capital expenditure line, from 0.375% to 0.500%. Upon meeting the minimum FCCR requirement of 1.15:1 on a twelve ~~months~~month trailing basis, the Facility Fee rate of 0.375% will be reinstated.

In connection with the amendment, we paid our lender a fee of $15,000 which is being amortized over the remaining term of the Amended Loan Agreement ~~as amended,~~ as interest expense-financing fees.

On August 2, 2022, we entered into an amendment to our Amended Loan Agreement with our lender which provided the following, among other things:
29 ● waived our failure to meet the minimum quarterly FCCR requirement for the second quarter of 2022;
● removes the quarterly FCCR testing requirement for the third quarter of 2022;
● reinstates the quarterly FCCR testing requirement starting for the fourth quarter of 2022 and revises the methodology to be used in calculating the FCCR for the quarters ending December 31, 2022 and March 31, 2023 (with no change to the minimum 1.15:1 ratio requirement for each quarter);
● requires maintenance of a minimum of $3,000,000 in borrowing availability under the revolving credit until the minimum FCCR requirement for the quarter ended December 31, 2022 has been met and certified to the lender.

~~Pursuant to~~In connection with the amendment, we paid our lender a fee of $15,000 which is being amortized over the remaining term of the Amended Loan Agreement as ~~amended, payment of annual rate of~~ interest due on the revolving credit is at prime (3.50% at March 31, 2022) plus 2% or LIBOR plus 3.00% and the term loan and capital expenditure line at prime plus 2.50% or LIBOR plus 3.50%. Under the LIBOR option of interest payment, a LIBOR floor of 0.75% applies in the event that LIBOR falls below 0.75% at any point in time.expense-financing fees.

Our credit facility under our Amended Loan Agreement ~~as amended,~~ with PNC contains certain financial covenants, along with customary representations and warranties. A breach of any of these financial covenants, unless waived by PNC, could result in a default under our credit facility allowing our lender to immediately require the repayment of all outstanding debt under our credit facility and terminate all commitments to extend further credit. We were not required to perform testing of the FCCR requirement in the first ~~quarter~~and third quarters of 2022 pursuant to the March 29, 2022 and August 2, 2022 amendments, respectively, as discussed above. We failed to meet our FCCR requirement in the second quarter of 2022; however, this non-compliance was waived by our lender pursuant to the August 2, 2022 amendment as discussed ~~above; otherwise,~~above. Other than the FCCR covenant discussion above, we met all of our other financial covenant ~~requirements.~~requirements in the first, second and third quarters of 2022. We expect to meet our quarterly financial covenant requirements for the next twelve months under our Amended Loan Agreement.

37
On August 29, 2022, we entered into an amendment to our Amended Loan Agreement with our lender which set forth certain revisions to our Amended Loan Agreement, with the amended terms set forth in a revised Loan Agreement. The new revisions to the Amended Loan Agreement (the “Revised Loan Agreement”) among other things, replaced the London InterBank Offer Rate (“LIBOR”) based interest rate benchmark with the Secured Overnight Finance Rate (“SOFR”) and added certain additional anti-terrorism provisions to the covenants contained in the Amended Loan Agreement. As a result of this amendment, payment of annual rate of interest due on the revolving credit is at prime (6.25% at September 30, 2022) plus 2% or Term SOFR Rate (as defined in the Revised Loan Agreement) plus 3.00% plus an SOFR Adjustment applicable for an interest period selected by us and payment of annual rate of interest due on the term loan and the capital expenditure line is at prime plus 2.50% or Term SOFR Rate plus 3.50% plus an SOFR Adjustment applicable for an interest period selected by us. Pursuant to the Revised Loan Agreement, SOFR Adjustment rates of 0.10% and 0.15% are applicable for a one-month interest period and three-month period, respectively, that may be selected by us.
After May 7, 2022, we may terminate its Revised Loan Agreement upon 90 days’ prior written notice upon payment in full of our obligations under the Revised Loan Agreement with no early termination fees.
Employee Retention Credit (“ERC”)
The CARES Act, which was enacted on March 27, 2020, provides an ERC for qualifying businesses keeping employees on their payroll during the COVID-19 pandemic. The ERC was subsequently amended by the Taxpayer Certainty and Disaster Tax Relief Act of 2020, the Consolidated Appropriation Act of 2021, and the American Rescue Plan Act of 2021, all of which amended and extended the ERC availability and guidelines under the CARES Act. Following these amendments, we determined that we were eligible for the ERC, and as a result of the foregoing legislations, are eligible to claim a refundable tax credit against our share of certain payroll taxes equal to 70% of the qualified wages paid to employees between July 1, 2021 and September 30, 2021. Qualified wages are limited to $10,000 per employee per calendar quarter in 2021 for a maximum allowable ERC per employee of $7,000 per calendar quarter in 2021. For purposes of the amended ERC, an eligible employer is defined as having experienced a significant (20% or more) decline in gross receipts during one or more of the first three 2021 calendar quarters when compared to 2019.
During the third quarter of 2022, we determined we were eligible for the ERC and amended our third quarter 2021 employer payroll tax filings claiming a refund from the U.S. Treasury in the amount of approximately $1,975,000. As there is no authoritative guidance under U.S. GAAP on accounting for government assistance to for-profit business entities, we account for the ERC by analogy to International Accounting Standard (“IAS”) 20, Accounting for Government Grants and Disclosure of Government Assistance. In accordance with IAS 20, management determined it has reasonable assurance for receipt of the ERC and recorded the expected refund as other income (within “Other income (expense)”) on our Consolidated Statements of Operations and other receivables (within “Prepaid and other assets”) on our Consolidated Balance Sheets.
Off Balance Sheet Arrangements

From time to time, we are required to post standby letters of credit and various bonds to support contractual obligations to customers and other obligations, including facility closures. At ~~March 31,~~September 30, 2022, the total amount of standby letters of credit outstanding totaled approximately ~~$3,020,000~~$3,016,000 and the total amount of bonds outstanding totaled approximately ~~$51,295,000.~~$59,322,000. We also provide closure and post-closure requirements through a financial assurance policy for certain of our Treatment Segment facilities through AIG. At ~~March 31,~~September 30, 2022, the closure and post-closure requirements for these facilities were approximately ~~$21,047,000.~~$21,175,000.

Critical Accounting Policies and Estimates

There were no significant changes in our accounting policies or critical accounting estimates that are discussed in our Annual Report on Form 10-K for the year ended December 31, 2021.

Recent Accounting Pronouncements

See “Note 2 – Summary of Significant Accounting Policies” in the “Notes to Consolidated Financial Statements” for the recent accounting pronouncements that have been adopted during the ~~quarter ended March 31,~~first nine months of 2022, or will be adopted in future periods.

38
Known Trends and Uncertainties
Significant Customers. Our Treatment and Services Segments have significant relationships with the U.S governmental authorities through contracts entered into indirectly as subcontractors for others who are prime contractors or directly as the prime contractor to government authorities. We also had significant relationships with Canadian government authorities primarily through TOAs entered into with Canadian government authorities. Project work under all TOAs with Canadian government authorities has substantially been completed. The contracts that we are a party to with others as subcontractors to the U.S federal government or directly with the U.S federal government generally provide that the government may terminate the contract at any time for convenience at the government’s option. The contracts/TOAs that we are a party to with Canadian governmental authorities also generally provide that the government authorities may terminate the contracts/TOAs at any time for any reason for convenience. Our inability to continue under existing contracts that we have with the U.S government (directly or indirectly as a subcontractor) or significant reductions in the level of governmental funding in any given year could have a material adverse impact on our operations and financial condition.
We performed services relating to waste generated by government clients (domestic and foreign (primarily Canadian)), either ~~indirectly as a subcontractor or~~ directly as a prime contractor or indirectly for others as a subcontractor to government entities, representing approximately ~~$14,158,000~~$15,279,000 or ~~89.0%~~82.7% and $46,488,000 or 86.3% of our total ~~revenue~~revenues generated during the three and nine months ended ~~March 31,~~September 30, 2022, respectively, as compared to ~~$20,157,000~~$13,244,000 or ~~87.1%~~83.8% and $47,267,000 or 85.8% of our total ~~revenue~~revenues generated during the ~~corresponding period of 2021.~~three and nine months ended September 30, 2021, respectively.
COVID-19 Impact. See “COVID-19 ~~Impact~~ and ~~Impact due to~~ Other ~~Delays”~~Impacts” within this MD&A for a discussion of the impact of COVID-19 and other on our financial results and the potential impact it may have toon our future financial results and business operations.
30

Perma-Fix Canada, Inc. (“PF Canada”)

During the fourth quarter of 2021, PF Canada received a Notice of Termination (“NOT”) from CNL on a TOA that PF Canada entered into with CNL in May 2019 for remediation work within Ontario, Canada (“Agreement”). The NOT was received after work under the TOA was substantially completed and work under the TOA has since been completed. CNL may terminate the TOA at any time for convenience. As of ~~March 31,~~September 30, 2022, PF Canada has approximately ~~$2,722,000~~$2,385,000 in unpaid receivables ~~and unbilled costs~~ due from CNL as a result of work performed under the TOA. Additionally, CNL has approximately ~~$1,150,000~~$1,044,000 in contractual holdback under the TOA that is payable to PF Canada. CNL also established a bond securing approximately $1,900,000 (CAD) to cover certain issue raised in connection with the TOA. Under the TOA, CNL may be entitled to set off certain costs and expenses incurred by CNL in connection with the termination of the TOA, including the bond as discussed above, against amounts owed to PF Canada for work performed by PF Canada or its subcontractors. PF Canada continues to be in discussions with CNL to finalize the amounts due to PF Canada under the TOA and continues to ~~believes~~believe these amounts are due and payable.
Potential Partnership with Springfields Fuels Limited. As discussed above, we have signed a term sheet addressing plans to partner with Springfields Fuels Limited, an affiliate of Westinghouse Electric Company LLC, to develop and manage a nuclear waste-materials treatment facility in the United Kingdom. See “Liquidity and Capital Resources – Investing Activities” of this MD&A for a discussion of this transaction.

Supply Chain. We use various commercially available materials and supplies which include among other things chemicals, containers/drums and personal protective equipment in our operations. We generally source these items from various suppliers in order to take advantage of competitive pricing.

39
We also utilize various types of equipment, which include among other things trucks, flatbeds, lab equipment, heavy ~~machineries,~~machinery, in carrying out our business operations. Our equipment may be obtained through direct purchase, rental option or leases. Within our Services Segment, equipment required for projects are often provided by our subcontractors as part of our contract agreement with the subcontractor. Due to some of our specialized waste treatment processes, certain equipment that we utilize are designed and built to our specifications. We rely on various commercial equipment suppliers for the construction of these equipment. Due to ~~recent~~ supply chain challenges, we previously experienced a delay in the delivery of a new waste processing unit to us by our supplier due to shortage of parts required for the construction of the unit, among other ~~things. Delivery of this unit was expected during the third quarter of 2021 but did not occur until the latter part of the first quarter of 2022. The~~things, This supply chain interruption delayed deployment of our new technology which negatively impacted our revenue for 2021 and the first quarter of 2022 as associated revenue was not able to be generated. Deployment of this unit ~~is expected to commence~~commenced in ~~the second quarter~~mid-May of 2022. Continued increases in pricing and/or potential delays in procurements of material and supplies and equipment required for our operations resulting from further tightening supply chain could further adversely affect our operations and profitability.
~~Potential Partnership with Springfields Fuels Limited.~~ As discussed above, we have signed a term sheet addressing plans to partner with Springfields Fuels Limited, an affiliate of Westinghouse Electric Company LLC, to develop and manage a nuclear waste-materials treatment facility in the United Kingdom. See “Liquidity and Capital Resources – Investing Activities” of this MD&A for a discussion of this transaction.

Inflation and Cost Increases. Continued increases in any of our operating costs, including further changes in fuel prices (which impacts our transportation costs), wage rates, supplies, and utility costs, may further increase our overall cost of goods sold or operating expenses. Some of these cost increases have been the result of inflationary pressures that could further reduce profitability. We may attempt to increase our sales prices in order to maintain satisfactory margin; however, competitive pressures in our industry may have the effect of inhibiting our ability to reflect these increased costs in the prices of our services that we provide to our customers and therefore reduce our profitability.

Environmental Contingencies

We are engaged in the waste management services segment of the pollution control industry. As a participant in the on-site treatment, storage and disposal market and the off-site treatment and services market, we are subject to rigorous federal, state and local regulations. These regulations mandate strict compliance and therefore are a cost and concern to us. Because of their integral role in providing quality environmental services, we believe we make every reasonable attempt to maintain complete compliance with these regulations; however, even with a diligent commitment, we, along with many of our competitors, may be required to pay fines for violations or investigate and potentially remediate our waste management facilities.
31

We routinely use third party disposal companies, who ultimately destroy or secure landfill residual materials generated at our facilities or at a client’s site. In the past, numerous third-party disposal sites have improperly managed waste and consequently require remedial action; consequently, any party utilizing these sites may be liable for some or all of the remedial costs. Despite our aggressive compliance and auditing procedures for disposal of wastes, we could further be notified, in the future, that we are a potentially responsible party (“PRP”) at a remedial action site, which could have a material adverse effect.

We have three environmental remediation projects, all within our discontinued operations, which principally entail the removal/remediation of contaminated soil, and, in most cases, the remediation of surrounding ground water. We expect to fund the expenses to remediate these sites from funds generated from operations. At ~~March 31,~~September 30, 2022, we had total accrued environmental remediation liabilities of ~~$876,000, with no change~~$861,000, a decrease of $15,000 from the December 31, 2021 balance of $876,000. The decrease represents payments for remediation projects. At ~~March 31,~~September 30, 2022, ~~$621,000~~$751,000 of the total accrued environmental liabilities was recorded as current.

~~Item 3.~~ ~~Quantitative and Qualitative Disclosures about Market Risks~~
Item 3. Quantitative and Qualitative Disclosures about Market Risks
Not ~~required for smaller reporting companies.~~applicable
40
~~Item 4.~~
Item 4. Controls and Procedures
(a) Evaluation of disclosure controls and procedures.

~~(a)~~
~~Evaluation of disclosure controls, and procedures.~~
We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our periodic reports filed with the Securities and Exchange Commission is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission and that such information is accumulated and communicated to our management. As of the end of the period covered by this report, we carried out an evaluation with the participation of our Principal Executive Officer and Principal Financial Officer. Based on this recent assessment, our Principal Executive Officer and Principal Financial Officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended) were not effective as of ~~March 31,~~September 30, 2022 as a result of the identified material weakness in our internal control over financial reporting as ~~set forth below.~~discussed in more detail below and in our 2021 Form 10-K filing.

~~Certain revenue contracts~~
As previously disclosed in our 2021 Form 10-K, management concluded that ~~contained nonstandard terms and conditions were not appropriately evaluated~~a material weakness existed in ~~accordance with ASC 606, “Revenue from Contracts with Customers.” Specifically,~~our internal control over financial reporting because management did not have the appropriate controls in place over the determination of revenue recognition for nonroutine and complex revenue ~~transactions. The material weakness identified resulted~~transactions in ~~errors~~accordance with ASC 606, “Revenue from Contracts with Customers” in ~~the Company’s books~~certain contracts that contained nonstandard terms and records which led to audit adjustments for the year ended December 31, 2021. The errors arising from the underlying revenue adjustments were not material to the financial statements reported in any interim or annual period and therefore, did not result in a revision to any previously filed financial statements. However, the control deficiencies could result in misstatements of the revenue accounts and related disclosures that would result in a material misstatement to the annual or interim consolidated financial statements that would not be prevented or detected in a timely manner. Accordingly, we have determined that the control deficiencies when evaluated in the aggregate constitute a material weakness.conditions.
32
Remediation of Material Weakness in Internal Control Over Financial Reporting
~~The~~
In order to remediate this material weakness, ~~as discussed above was primarily attributed~~management has implemented its remediation plan which included the following:
● consultation with third-party expertise for guidance on large and/or unique contracts to ~~the uniqueness of certain of~~ensure ASC 606 guidance are accurately applied and documented;
● updated our ASC 606 revenue templates to ensure unique contract provisions are able to be identified so ASC 606 guidance are applied accurately;
● instituted more robust collaboration with the Company’s ~~contracts that contain~~operation personnel to identify nonstandard contract terms in order to determine appropriate treatment under ASC 606; and
● continue training of accounting and ~~conditions. Although the Company’s policies~~operations personnel on ASC 606 by subject matter experts and ~~procedures were in place~~internal financial department to ensure proper application of guidance under ASC ~~606 were applied~~606.
Management is committed to improving our internal control processes and believes that the ~~majority of its contracts accurately, the Control failed to operate in a manner to specifically identify the nonstandard terms that would impact revenue recognition. The Company is evaluating~~measures described above should remediate the material weakness identified above and ~~is developing a plan of remediation to~~ strengthen our internal controls pertaining to evaluating revenue contracts that contain nonstandard terms and conditions. This remediation plan includes evaluating the manner in which we use third-party consulting firms with expertise in applying the revenue recognition guidance that will assist management with the assessment and evaluation of revenue contracts executed that contain nonstandard terms and conditions. In conjunction with further evaluation of this relationship, management will also perform a more rigorous evaluation of these nonstandard revenue contracts in accordance with ASC 606.
~~The Company is committed to maintaining a strong~~ internal control ~~environment~~over financial reporting. As we continue to evaluate and believes that these remediation efforts will represent significant improvements in our controls. The Company has started to implement these steps, however, some of these steps will take time to be fully integrated and confirmed to be effective and sustainable. Additional controls may also be requiredimprove internal control over ~~time. Until the remediation steps set forth above are fully implemented and tested,~~financial reporting resulting from the material weakness described above, additional measures to remediate the material weakness may be necessary. The material weakness will ~~continue to exist.~~not be considered remediated until the applicable remediated controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively. At this time, notwithstanding the material weakness in our internal control over financial reporting as described above, we believe that our consolidated financial statements contained in this Quarterly Report on Form 10-Q fairly present our financial position, results of operations and cash flows for the period covered thereby.

(b) Changes in internal control over financial ~~reporting~~reporting.
~~Other than~~Except for the ~~aforementioned material weakness and~~ remediation ~~plan noted,~~procedures implemented by the Company as described above, there ~~was~~have been no other change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during our most recently completed fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
41
PART II – OTHER INFORMATION

~~Item 1.~~ ~~Legal Proceedings~~
Item 1. Legal Proceedings

There are no material legal proceedings pending against us and/or our subsidiaries not previously reported by us in Item 3 of our Form 10-K for the year ended December 31, 2021. Additionally, there has been no other material change in legal proceedings previously disclosed by us in our Form 10-K for the year ended December 31, 2021.

~~Item 1A.~~ ~~Risk Factors~~
Item 1A. Risk Factors

There has been no other material change from the risk factors previously disclosed in our Form 10-K for the year ended December 31, 2021, ~~except~~and our Form 10-Q for the ~~following under “Risks Relating to our Common Stock.”~~quarter ended March 31, 2022.

Our bylaws designate courts in the State of Delaware as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by our stockholders, and also designates the Federal District Courts of the United States as the sole and exclusive forum for resolution of any cause of action arising under the Securities Act of 1933, as amended, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, officers or employees.Item 6. Exhibits
Our Bylaws provide that, subject to limited exceptions, the appropriate state court located in the State of Delaware (or if no state court located within the State of Delaware has jurisdiction, the Federal District Court for the District of Delaware) is the sole and exclusive forum for:

● ~~any derivative action or proceeding brought on our behalf;~~
● ~~any action asserting a claim of breach of a fiduciary duty owed by any of our current or former directors, officers or other employees to us or our stockholders;~~
33
● ~~any action asserting a claim against us arising pursuant to any provision of the General Corporation Law of the State of Delaware, our certificate of incorporation or our bylaws:~~
● ~~any action asserting an “internal corporation claim” (as defined in Section 115 of the Delaware General Corporate Law); or~~
● ~~any other action asserting a claim against us that is governed by the internal affairs doctrine (each, a “Covered Proceeding”).~~
In addition, our Bylaws provide that if any action the subject matter of which is a Covered Proceeding is filed in a court other than the specified Delaware courts without the approval of our Board of Directors (each, a “Foreign Action”), the claiming party will be deemed to have consented to (i) the personal jurisdiction of the specified Delaware courts in connection with any action brought in any such courts to enforce the exclusive forum provision described above and (ii) having service of process made upon such claiming party in any such enforcement action by service upon such claiming party’s counsel in the Foreign Action as agent for such claiming party.
Further, our Bylaws provide that, unless we consent in writing to the selection of an alternative forum, the Federal District Courts of the United States shall be the sole and exclusive forum for the resolution of any complaint asserting a course of action under the Federal Securities Act of 1933, as amended.
These provisions may limit a stockholder’s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers or other employees, which may discourage such lawsuits against us and our directors, officers and employees. Alternatively, if a court were to find these provisions of our Bylaws inapplicable to, or unenforceable in respect of, one or more of the specified types of actions or proceedings, we may incur additional costs associated with resolving such matters in other jurisdictions, which could adversely affect our business and financial condition.
~~Item 6.~~ ~~Exhibits~~
(a) Exhibits
4.1 ~~Third~~Fifth Amendment to Second Amended and Restated Revolving Credit, Term Loan and Security Agreement dated August 29, 2022, as incorporated by reference from Exhibit 4.1 to the Company’s Form 8-K filed on August 29, 2022.
4.2 Revised Second Amended and Restated Revolving Credit, Term Loan and Security Agreement referenced as Annex A in the Fifth Amendment, as incorporated by reference from Exhibit 4.2 to the Company’s Form 8-K filed on August 29, 2022.
4.3 Fourth Amendment to Second Amended and Restated Revolving Credit, Term Loan and Security Agreement between Perma-Fix Environmental Services, Inc. and PNC Bank, National Association (as Lender and as Agent), dated ~~March 29,~~August 2, 2022, as incorporated by reference from Exhibit ~~4.1~~4.3 to the ~~Company’s~~Company Form ~~8-K~~10-Q for the quarter ended June 30, 2022 filed on ~~April 4,~~August 5, 2022.
10.1 2022 Incentive Compensation Plan for Chief Executive Officer, effective January 1, 2022, as incorporated by reference from Exhibit 99.5 to the Company’s Form 8-K filed on January 25, 2022. CERTAIN INFORMATION WITHIN THIS EXHIBIT HAS BEEN EXCLUDED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED.
~~10.2~~ 2022 Incentive Compensation Plan for Chief Financial Officer, effective January 1, 2022, as incorporated by reference from Exhibit 99.6 to the Company’s Form 8-K filed on January 25, 2022. CERTAIN INFORMATION WITHIN THIS EXHIBIT HAS BEEN EXCLUDED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED.
34
~~10.3~~ 2022 Incentive Compensation Plan for EVP of Strategic Initiatives, effective January 1, 2022, as incorporated by reference from Exhibit 99.7 to the Company’s Form 8-K filed on January 25, 2022. CERTAIN INFORMATION WITHIN THIS EXHIBIT HAS BEEN EXCLUDED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED.
~~10.4~~ 2022 Incentive Compensation Plan for EVP of Nuclear and Technical Services, effective January 1, 2022, as incorporated by reference from Exhibit 99.8 to the Company’s Form 8-K filed on January 25, 2022. CERTAIN INFORMATION WITHIN THIS EXHIBIT HAS BEEN EXCLUDED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED.
~~10.5~~ 2022 Incentive Compensation Plan for EVP of Waste Treatment Operations, effective January 1, 2022, as incorporated by reference from Exhibit 99.9 to the Company’s Form 8-K filed on January 25, 2022. CERTAIN INFORMATION WITHIN THIS EXHIBIT HAS BEEN EXCLUDED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED.
~~10.6~~ Joint Venture Term Sheet between Springfields Fuels Limited, an affiliate of Westinghouse, and the Company, as incorporated by reference from Exhibit 10.42 to the Company’s 2021 Form 10-K filed on April 6, 2022. CERTAIN INFORMATION WITHIN THIS EXHIBIT HAS BEEN EXCLUDED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED.
31.1 Certification by Mark Duff, Chief Executive Officer of the Company pursuant to Rule 13a-14(a) or 15d-14(a).
31.2 Certification by Ben Naccarato, Chief Financial Officer of the Company pursuant to Rule 13a-14(a) or 15d-14(a).
32.1 Certification by Mark Duff, Chief Executive Officer of the Company furnished pursuant to 18 U.S.C. Section 1350.
32.2 Certification by Ben Naccarato, Chief Financial Officer of the Company furnished pursuant to 18 U.S.C. Section 1350.
101.INS Inline XBRL Instance Document*Document-the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document*
101.SCH Inline XBRL Taxonomy Extension Schema Document*
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document*
101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document*
101.LAB Inline XBRL Taxonomy Extension Labels Linkbase Document*

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase Document*
104 Cover Page Interactive Data File ~~(embedded within the~~(formatted as an Inline XBRL ~~document)~~document and included in Exhibit 101).

* Pursuant to Rule 406T of Regulation S-T, the Inline Interactive Data File in Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Section 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purpose of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.

3542

SIGNATURES
Pursuant to the requirements of the Securities ~~and~~ Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

PERMA-FIX ENVIRONMENTAL SERVICES

Date: ~~May 5,~~November 3, 2022 By: /s/ Mark Duff

Mark Duff
President and Chief (Principal) Executive Officer

Date: ~~May 5,~~November 3, 2022 By: /s/ Ben Naccarato
Ben Naccarato
Chief (Principal) Financial Officer

3643

	March 31,			December 31
	2022			2021
(Amounts in Thousands, Except for Share and per Share Amounts)	(Unaudited)			(Audited)

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	10,329		$	11,975
Accrued expenses		5,537			5,078
Disposal/transportation accrual		1,162			1,065
Deferred revenue		2,707			5,580
Accrued closure costs - current		547			578
Current portion of long-term debt		384			393
Current portion of operating lease liabilities		416			406
Current portion of finance lease liabilities		354			333
Current liabilities related to discontinued operations		802			506
Total current liabilities		22,238			25,914

Accrued closure costs		6,706			6,613
Long-term debt, less current portion		491			600
Long-term operating lease liabilities, less current portion		1,921			2,029
Long-term finance lease liabilities, less current portion		920			884
Long-term liabilities related to discontinued operations		408			677
Total long-term liabilities		10,446			10,803

Total liabilities		32,684			36,717

Commitments and Contingencies (Note 9 )		—			—

Stockholders’ Equity:
Preferred Stock, $.001 par value; 2,000,000 shares authorized, 0 shares issued and outstanding		—			—
Common Stock, $.001 par value; 30,000,000 shares authorized; 13,242,072 and 13,222,552 shares issued, respectively; 13,234,430 and 13,214,910 shares outstanding, respectively		13			13
Additional paid-in capital		114,532			114,307
Accumulated deficit		(74,963	)		(73,620	)
Accumulated other comprehensive loss		(2	)		(28	)
Less Common Stock in treasury, at cost; 7,642 shares		(88	)		(88	)
Total stockholders’ equity		39,492			40,584

Total liabilities and stockholders’ equity	$	72,176		$	77,301

(Amounts in Thousands, Except for Per Share Amounts)	2022			2021			2022			2021			2022			2021
							Three Months Ended						Nine Months Ended
	Three Months Ended March 31,						September 30,						September 30,
(Amounts in Thousands, Except for Per Share Amounts)	2022			2021			2022			2021			2022			2021

Revenues	$	15,915		$	23,133
Net revenues							$	18,472		$	15,797		$	53,842		$	55,075
Cost of goods sold		14,279			20,777			15,402			13,573			46,252			49,529
Gross profit		1,636			2,356			3,070			2,224			7,590			5,546

Selling, general and administrative expenses		3,422			3,205			3,929			3,348			11,035			9,550
Research and development		96			150			69			243			245			538
Loss on disposal of property and equipment		1			—			—			1			1			1
Loss from operations		(1,883	)		(999	)		(928	)		(1,368	)		(3,691	)		(4,543	)

Other income (expense):
Interest income		11			18			29			2			69			23
Interest expense		(35	)		(67	)		(47	)		(77	)		(123	)		(209	)
Interest expense-financing fees		(13	)		(8	)		(16	)		(11	)		(44	)		(28	)
Other		(2	)		1
Loss from continuing operations before taxes		(1,922	)		(1,055	)
Income tax benefit		(673	)		(17	)
Loss from continuing operations, net of taxes		(1,249	)		(1,038	)
Other (Note 13)								1,965			(1	)		1,960			—
Gain on extinguishment of debt								—			—			—			5,381
Income (loss) from continuing operations before taxes								1,003			(1,455	)		(1,829	)		624
Income tax expense (benefit)								179			(2,836	)		(147	)		(2,840	)
Income (loss) from continuing operations, net of taxes								824			1,381			(1,682	)		3,464

Loss from discontinued operations (net of taxes) (Note 10)		(94	)		(115	)
Net loss		(1,343	)		(1,153	)
Loss from discontinued operations, net of taxes (Note 10)								(160	)		(43	)		(442	)		(285	)
Net income (loss)								664			1,338			(2,124	)		3,179

Net loss attributable to non-controlling interest		—			(30	)		—			(64	)		—			(123	)

Net loss attributable to Perma-Fix Environmental Services, Inc. common stockholders	$	(1,343	)	$	(1,123	)
Net income (loss) attributable to Perma-Fix Environmental Services, Inc. common stockholders							$	664		$	1,402		$	(2,124	)	$	3,302

Net loss per common share attributable to Perma-Fix Environmental Services, Inc. stockholders - basic and diluted:
Net income (loss) per common share attributable to Perma-Fix Environmental Services, Inc. stockholders - basic:
Continuing operations	$	(.09	)	$	(.08	)	$	.06		$	.12		$	(.13	)	$	.29
Discontinued operations		(.01	)		(.01	)		(.01	)		(.01	)		(.03	)		(.02	)
Net loss per common share	$	(.10	)	$	(.09	)
Net income (loss) per common share							$	.05		$	.11		$	(.16	)	$	.27

Number of common shares used in computing net loss per share:
Net income (loss) per common share attributable to Perma-Fix Environmental Services, Inc. stockholders - diluted:
Continuing operations							$	.06		$	.12		$	(.13	)	$	.29
Discontinued operations								(.01	)		(.01	)		(.03	)		(.02	)
Net income (loss) per common share							$	.05		$	.11		$	(.16	)	$	.27

Number of common shares used in computing net income (loss) per share:
Basic		13,234			12,165			13,297			12,198			13,265			12,181
Diluted		13,234			12,165			13,447			12,406			13,265			12,416

(Amounts in Thousands)	2022			2021
	Three Months Ended March 31,
(Amounts in Thousands)	2022			2021

Net loss	$	(1,343	)	$	(1,153	)
Other comprehensive income:
Foreign currency translation gain		26			20
Total other comprehensive income		26			20

Comprehensive loss		(1,317	)		(1,133	)
Comprehensive loss attributable to non-controlling interest		—			(30	)
Comprehensive loss attributable to Perma-Fix Environmental Services, Inc. stockholders	$	(1,317	)	$	(1,103	)

	Shares		Amount		Capital		Treasury			Loss			Subsidiary			Deficit			Equity
	Common Stock				Additional Paid-In		Common Stock Held In			Accumulated Other Comprehensive			Non-controlling Interest in			Accumulated			Total Stockholders’
	Shares		Amount		Capital		Treasury			Loss			Subsidiary			Deficit			Equity

Balance at December 31, 2021		13,222,552	$	13	$	114,307	$	(88	)	$	(28	)	$	—		$	(73,620	)	$	40,584
Net loss		—		—		—		—			—			—			(1,343	)		(1,343	)
Foreign currency translation		—		—		—		—			26			—			—			26
Issuance of Common Stock for services		19,520		—		123		—			—			—			—			123
Stock-Based Compensation		—		—		102		—			—			—			—			102
Balance at March 31, 2022		13,242,072	$	13	$	114,532	$	(88	)	$	(2	)	$	—		$	(74,963	)	$	39,492

Balance at December 31, 2020		12,161,539	$	12	$	108,931	$	(88	)	$	(207	)	$	(1,742	)	$	(74,455	)	$	32,451
Net loss		—		—		—		—			—			(30	)		(1,123	)		(1,153	)
Foreign currency translation		—		—		—		—			20			—			—			20
Issuance of Common Stock for services		11,837		—		79		—			—			—			—			79
Stock-Based Compensation		—		—		45		—			—			—			—			45
Balance at March 31, 2021		12,173,376	$	12	$	109,055	$	(88	)	$	(187	)	$	(1,772	)	$	(75,578	)	$	31,442

Revenue by Contract Type
(In thousands)	Three Months Ended						Three Months Ended						Three Months Ended						Three Months Ended
	March 31, 2022						March 31, 2021						September 30, 2022						September 30, 2021
	Treatment		Services		Total		Treatment		Services		Total		Treatment		Services		Total		Treatment		Services		Total
Fixed price	$	7,479	$	5,761	$	13,240	$	7,495	$	2,581	$	10,076	$	8,877	$	6,892	$	15,769	$	8,893	$	3,031	$	11,924
Time and materials		—		2,675		2,675		—		13,057		13,057		—		2,703		2,703		—		3,873		3,873
Total	$	7,479	$	8,436	$	15,915	$	7,495	$	15,638	$	23,133	$	8,877	$	9,595	$	18,472	$	8,893	$	6,904	$	15,797

Revenue by generator
(In thousands)	Three Months Ended						Three Months Ended
	March 31, 2022						March 31, 2021
	Treatment		Services		Total		Treatment		Services		Total
Domestic government	$	5,815	$	8,245	$	14,060	$	4,598	$	12,661	$	17,259
Domestic commercial		1,436		162		1,598		2,265		590		2,855
Foreign government		92		6		98		534		2,364		2,898
Foreign commercial		136		23		159		98		23		121
Total	$	7,479	$	8,436	$	15,915	$	7,495	$	15,638	$	23,133

					Year-to-date			Year-to-date							Year-to-date			Year-to-date
(In thousands)	March 31, 2022		December 31, 2021		Change ($)			Change (%)			September 30, 2022		December 31, 2021		Change ($)			Change (%)
Contract liabilities
Deferred revenue	$	2,707	$	5,580	$	(2,873	)		(51.5	)%	$	3,145	$	5,580	$	(2,435	)		(43.6	)%

	Operating Leases			Finance Leases			Operating Leases			Finance Leases
Weighted average remaining lease terms (years)		6.7			4.0			6.4			3.4

Weighted average discount rate		7.6	%		6.1	%		7.8	%		5.3	%

			March 31, 2022							December 31, 2021
	Weighted Average Amortization		Gross					Net		Gross					Net		Weighted Average		September 30, 2022							December 31, 2021
	Period		Carrying		Accumulated			Carrying		Carrying		Accumulated			Carrying		Amortization Period		Gross Carrying		Accumulated			Net Carrying		Gross Carrying		Accumulated			Net Carrying
	(Years)		Amount		Amortization			Amount		Amount		Amortization			Amount		(Years)		Amount		Amortization			Amount		Amount		Amortization			Amount
Other Intangibles (amount in thousands)
Patent		8.3	$	787	$	(354	)	$	433	$	787	$	(351	)	$	436		8.6	$	744	$	(369	)	$	375	$	787	$	(351	)	$	436
Software		3		606		(428	)		178		592		(415	)		177		3		636		(453	)		183		592		(415	)		177
Customer relationships		10		3,370		(3,129	)		241		3,370		(3,089	)		281		10		3,370		(3,209	)		161		3,370		(3,089	)		281
Total			$	4,763	$	(3,911	)	$	852	$	4,749	$	(3,855	)	$	894		-	$	4,750	$	(4,031	)	$	719	$	4,749	$	(3,855	)	$	894

	Amount		Amount
Year	(In thousands)		(In thousands)

2022 (Remaining)	$	164
2022(Remaining)			$	57
2023		178		187
2024		46		61
2025		11		11
2026		11		11

	Outside Director Stock Option Granted			Employee Stock Option Granted
	Nine Months Ended September 30, 2022
Weighted-average fair value per share	$	3.61		$	2.71
Risk-free interest rate ⁽¹⁾		2.91	%		3.00	%
Expected volatility of stock ⁽²⁾		55.04	%		55.72	%
Dividend yield		None			None
Expected option life ⁽³⁾		10.0 years			5.0 years

	Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (years)		Aggregate Intrinsic Value ⁽³⁾
Options outstanding January 1, 2022		1,019,400	$	4.91				—
Granted		—	$	—
Exercised		—	$	—			$	—
Forfeited/expired		—	$	—
Options outstanding end of period ⁽¹⁾		1,019,400	$	4.91		3.8	$	1,150,167
Options exercisable at March 31, 2022⁽¹⁾		455,900	$	3.92		2.5	$	779,362

	Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (years)		Aggregate Intrinsic Value ⁽³⁾
Options outstanding January 1, 2022		1,019,400		$	4.91				-
Granted		94,000		$	5.20
Exercised		(52,400	)	$	4.04			$	97,856
Forfeited/expired		(9,600	)	$	5.50
Options outstanding end of period ⁽¹⁾		1,051,400		$	4.98		4.0	$	492,939
Options exercisable at September 30, 2022⁽¹⁾		453,900		$	3.93		2.4	$	354,709

	●	waived the Company’s failure to meet the minimum quarterly fixed charge coverage ratio (“FCCR”) requirement for the fourth quarter of 2021;
	●	removes the quarterly FCCR testing requirement for the first quarter of 2022;
	●	reinstates the quarterly FCCR testing requirement starting for the second quarter of 2022 and revises the methodology to be used in calculating the FCCR for the quarters ending June 30, 2022, September 30, 2022, and December 31, 2022 (with no change to the minimum 1.15:1 ratio requirement for each quarter);
	●	requires maintenance of a minimum of ~~$3,000,000~~$3,000,000 in borrowing availability under the revolving credit until the minimum FCCR requirement for the quarter ended June 30, 2022 has been met and certified to the ~~lender;~~lender; and
	●	revises the annual rate used to calculate the Facility Fee (as defined in the Loan Agreement) on the revolving credit, with addition of the capital expenditure line, from 0.375% to 0.500%. Upon meeting the minimum FCCR requirement of 1.15:1 on a twelve ~~months~~month trailing basis, the Facility Fee rate of 0.375% will be reinstated.

	-	nuclear, low-level radioactive, mixed waste (containing both hazardous and low-level radioactive constituents), hazardous and non-hazardous waste treatment, processing and disposal services primarily through four uniquely licensed and permitted treatment and storage facilities; and
	-	R&D activities to identify, develop and implement innovative waste processing techniques for problematic waste streams.

		○	professional radiological measurement and site survey of large government and commercial installations using advanced methods, technology and engineering;
		○	integrated Occupational Safety and Health services including industrial hygiene (“IH”) assessments; hazardous materials surveys, e.g., exposure monitoring; lead and asbestos management/abatement oversight; indoor air quality evaluations; health risk and exposure assessments; health & safety plan/program development, compliance auditing and training services; and Occupational Safety and Health Administration (“OSHA”) citation assistance;
		○	global technical services providing consulting, engineering, project management, waste management, environmental, and decontamination and decommissioning field, technical, and management personnel and services to commercial and government customers; and
		○	on-site waste management services to commercial and governmental customers.

		○	technology-based services including engineering, decontamination and decommissioning (“D&D”), specialty services and construction, logistics, transportation, processing and disposal;
		○	remediation of nuclear licensed and federal facilities and the remediation cleanup of nuclear legacy sites. Such services capability includes: project investigation; radiological engineering; partial and total plant D&D; facility decontamination, dismantling, demolition, and planning; site restoration; logistics; transportation; and emergency response; and

	Treatment			Services			Segments Total			Corporate ⁽¹⁾			Consolidated Total
Revenue from external customers	$	8,877		$	9,595		$	18,472	$		—		$	18,472
Intercompany revenues		28			16			44			—			—
Gross profit		1,967			1,103			3,070			—			3,070
Research and development		55			—			55			14			69
Interest income		—			—			—			29			29
Interest expense		(20	)		(2	)		(22	)		(25	)		(47	)
Interest expense-financing fees		—			—			—			(16	)		(16	)
Depreciation and amortization		387			87			474			23			497
Segment income (loss) before income taxes		1,792			725			2,517			(1,514	)		1,003	⁽²⁾
Income tax expense		164			15			179			—			179
Segment income (loss)		1,628			710			2,338			(1,514	)		824
Expenditures for segment assets		149			39			188			1			189	⁽³⁾

	Treatment			Services			Medical			Segments Total			Corporate⁽¹⁾			Consolidated Total			Treatment			Services			Medical			Segments Total			Corporate ⁽¹⁾			Consolidated Total
Revenue from external customers	$	7,495		$	15,638		$	—		$	23,133		$	—		$	23,133		$	8,893		$	6,904			—		$	15,797		$	—		$	15,797
Intercompany revenues		660			7			—			667			—			—			220			5			—			225			—			—
Gross profit		925			1,431			—			2,356			—			2,356
Gross profit (negative gross profit)																				2,487			(263	)		—			2,224			—			2,224
Research and development		47			13			76			136			14			150			52			18			162			232			11			243
Interest income		—			—			—			—			18			18			—			—			—			—			2			2
Interest expense		(19	)		(8	)		—			(27	)		(40	)		(67	)		(51	)		(1	)		—			(52	)		(25	)		(77	)
Interest expense-financing fees		—			—			—			—			(8	)		(8	)		—			—			—			—			(11	)		(11	)
Depreciation and amortization		310			85			—			395			5			400			319			85			—			404			5			409
Segment (loss) income before income taxes		(119	)		555			(76	)		360			(1,415	)		(1,055	)
Income tax benefit		(17	)		—			—			(17	)		—			(17	)
Segment (loss) income		(102	)		555			(76	)		377			(1,415	)		(1,038	)
Segment income (loss) before income taxes																				1,317			(984	)		(162	)		171			(1,626	)		(1,455	)
Income tax expense (benefit)																				1			—			—			1			(2,837	)		(2,836	)⁽⁴⁾
Segment income (loss)																				1,316			(984	)		(162	)		170			1,211			1,381
Expenditures for segment assets		357			4			—			361			—			361	⁽²⁾		482			—			—			482			—			482	⁽⁶⁾

⁽¹⁾		Amounts reflect the activity for corporate headquarters not included in the segment information.

●	demand for our services;
●	reductions and improvement in the level of government funding in future years;
●	reducing operating costs and non-essential expenditures;
●	ability to meet loan agreement quarterly financial covenant requirements;
●	cash flow requirements;
●	Canadian receivable;
●	sufficient liquidity to continue business;
●	future results of operations and liquidity;
●	effect of economic disruptions on our business;
●	government funding for our services;
●	may not have liquidity to repay debt if our lender accelerates payment of our borrowings;
●	~~deployment of unit;~~
●	manner in which the applicable government will be required to spend funding to remediate various sites;
●	funding operations;
●	continued increases in pricing and/or further tightening supply chain;
●	fund capital expenditures from cash from operations and/or financing;
●	impact from COVID-19 and ~~impact from other delays;~~economic conditions;
●	continue improvement in waste ~~shipments;~~receipts and project work;
●	submitted bid;
●	fund remediation expenditures for sites from funds generated internally;
●	ownership percentage interest upon finalization of partnership agreement;
●	investment requirement upon finalization of joint venture;

●	positive trends;
●	collection of accounts receivables;
●	compliance with environmental regulations;
●	potential effect of being a PRP;
●	potential sites for violations of environmental laws and remediation of our facilities;

●	remediation of material weakness;
●	future price increases; and
●	continuation of contracts with federal government.

●	general economic conditions;
●	contract bids, including international markets;
●	material reduction in revenues;
●	inability to meet PNC covenant requirements;
●	inability to collect in a timely manner a material amount of receivables;
●	increased competitive pressures;
●	inability to maintain and obtain required permits and approvals to conduct operations;
●	public not accepting our new technology;
●	inability to develop new and existing technologies in the conduct of operations;
●	inability to maintain and obtain closure and operating insurance requirements;
●	inability to retain or renew certain required permits;
●	discovery of additional contamination or expanded contamination at any of the sites or facilities leased or owned by us or our subsidiaries which would result in a material increase in remediation expenditures;
●	delays at our third-party disposal site can extend collection of our receivables greater than twelve months;
●	refusal of third-party disposal sites to accept our waste;
●	changes in federal, state and local laws and regulations, especially environmental laws and regulations, or in interpretation of such;
●	requirements to obtain permits for TSD activities or licensing requirements to handle low level radioactive materials are limited or lessened;
●	potential increases in equipment, maintenance, operating or labor costs;
●	management retention and development;
●	financial valuation of intangible assets is substantially more/less than expected;
●	the requirement to use internally generated funds for purposes not presently anticipated;
●	inability to continue to be profitable on an annualized basis;
●	inability of the Company to maintain the listing of its Common Stock on the NASDAQ;
●	terminations of contracts with government agencies or subcontracts involving government agencies or reduction in amount of waste delivered to the Company under the contracts or subcontracts;
●	renegotiation of contracts involving government agencies;
●	federal government’s inability or failure to provide necessary funding to remediate contaminated federal sites;
●	disposal expense accrual could prove to be inadequate in the event the waste requires re-treatment;
●	inability to raise capital on commercially reasonable terms;
●	inability to increase profitable revenue;
●	impact of the ~~COVID-19;~~COVID-19 and economic uncertainties;

●	new governmental regulations;
●	lender refuses to waive non-compliance or revise our covenant so that we are in compliance;
●	continued supply chain interruptions;
●	continued inflationary pressures;
●	~~other unanticipated factors;~~recession;
●	challenge by regulatory authorities of our claim to the ERTC; and
●	risk factors and other factors set forth in “Special Note Regarding Forward-Looking Statements” contained in the Company’s 2021 Form 10-K and the “Forward-Looking Statements” contained in the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” (“MD&A”) of the first and second quarters 2022 Form 10-Qs and this ~~first~~third quarter 2022 Form 10-Q.

	Three Months Ended
	March 31,
Consolidated (amounts in thousands)	2022			%			2021			%
Revenues	$	15,915			100.0		$	23,133			100.0
Cost of good sold		14,279			89.7			20,777			89.8
Gross profit		1,636			10.3			2,356			10.2
Selling, general and administrative		3,422			21.5			3,205			13.9
Research and development		96			.6			150			.6
Loss on disposal of property and equipment		1			—			—			—
Loss from operations	$	(1,883	)		(11.8	)	$	(999	)		(4.3	)
Interest income		11			—			18			—
Interest expense		(35	)		(.2	)		(67	)		(.2	)
Interest expense-financing fees		(13	)		(.1	)		(8	)		—
Other		(2	)		—			1			—
Loss from continuing operations before taxes		(1,922	)		(12.1	)		(1,055	)		(4.5	)
Income tax benefit		(673	)		(4.3	)		(17	)		—
Loss from continuing operations	$	(1,249	)		(7.8	)	$	(1,038	)		(4.5	)

(In thousands)	2022		% Revenue		2021		% Revenue		Change			% Change
Treatment
Government waste	$	5,437		34.2	$	4,387		18.9	$	1,050			23.9
Hazardous/non-hazardous ⁽¹⁾		1,001		6.3		1,311		5.7		(310	)		(23.6	)
Other nuclear waste		1,041		6.5		1,797		7.8		(756	)		(42.1	)
Total		7,479		47.0		7,495		32.4		(16	)		(0.2	)

Services
Nuclear services		8,281		52.0		15,080		65.2		(6,799	)		(45.1	)
Technical services		155		1.0		558		2.4		(403	)		(72.2	)
Total		8,436		53.0		15,638		67.6		(7,202	)		(46.1	)

Total	$	15,915		100.0	$	23,133		100.0	$	(7,218	)		(31.2	)

			%				%
(In thousands)	2022		Revenue		2021		Revenue		Change
Treatment	$	6,841		91.5	$	6,570		87.7	$	271
Services		7,438		88.2		14,207		90.8		(6,769	)
Total	$	14,279		89.7	$	20,777		89.8	$	(6,498	)

(In thousands)	2022		% Revenue		2021		% Revenue		Change
Administrative	$	1,826		—	$	1,580		—	$	246
Treatment		1,144		12.9		1,066		12.0		78
Services		959		10.0		702		10.2		257
Total	$	3,929		21.3	$	3,348		21.2	$	581

	Three Months Ended September 30,							Nine Months Ended September 30,
(In thousands)	2022		2021		Change			2022		2021		Change
Administrative	$	14	$	11	$	3		$	43	$	35	$	8
Treatment		55		52		3			179		142		37
Services		—		18		(18	)		23		50		(27	)
PF Medical		—		162		(162	)		—		311		(311	)
Total	$	69	$	243	$	(174	)	$	245	$	538	$	(293	)